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Abstract 
 
Objective: To evaluate clinical and radiographic treatment outcomes after 
maxillomandibular advancement (MMA) surgery on subjects suffering from obstructive 
sleep apnea (OSA).  
Materials and Methods: This was a retrospective cohort analysis. Subjects underwent 
pre- and post-surgical polysomnography (PSG) studies and were also asked to complete 
a subjective self-assessment via the Epworth Sleepiness Scale (ESS) questionnaire. 
Twenty-two patients (11 male, 11 female) met the inclusion criteria.  
Results: The mean pre-surgical apnea-hypopnea index (AHI) score was 48.4 (+/-31.3) 
and mean ESS score was 11.6 (+/-4.6). After surgery, the mean AHI reduced to 14.0 
(+/-15.0) and ESS reduced to 5.7 (+/-3.5). Treatment success was observed in 19 of 22 
(86.4%) patients and 8 of 22 (36.4%) met the criteria for treatment cure.  
Conclusions: MMA surgery is an effective treatment for patients suffering from OSA. 
Subjective sleepiness levels were significantly reduced after surgery. There were no pre- 
or post-surgical variables that acted as predictors of successful treatment. 
 
Keywords 
Obstructive Sleep Apnea (OSA), Sleep Disordered Breathing, Maxillomandibular 
Advancement (MMA), Orthognathic Surgery, Epworth Sleepiness Scale (ESS), Apnea-
Hypopnea Index (AHI). 
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Introduction 
 Obstructive sleep apnea (OSA) is a syndrome that was first recognized in the 
medical literature in 1965. 1 It is characterized by partial or complete blockage of the 
airway during sleep referred to as hypopnea or apnea.  2 Apnea is identified by the 
complete inability to breath for at least ten seconds, despite an effort to breathe, whereas 
hypopnea is associated with a 30% reduction in thoraco-abdominal movement or airflow 
(when compared to a baseline), lasting at least ten seconds with 4% or more oxygen 
desaturation.  1 “Obstructive” sleep apnea can be differentiated from “central” sleep apnea 
by observing that, in an obstructive sleep apnea patient, a physical effort to inhale is 
made but the airway is blocked, preventing inspiration. In the case of central sleep apnea, 
there is no signal sent from the brain to make an effort to breathe, therefore the patient 
stops breathing even though the airway remains unobstructed.  3 
 Obstructive sleep apnea has a range of severity, which is measured via the apnea-
hypopnea index (AHI). This index is used to identify the number of episodes that occur 
per hour of sleep. To be considered as suffering from obstructive sleep apnea, a patient 
must obtain a minimum AHI score of five or greater and also report having excessive 
daytime sleepiness. Scores of five to 14 are classified as mild sleep apnea, 15 to 29 are 
termed moderate and patients who obtain scores of 30 or greater are categorized as 
suffering from severe obstructive apnea. 1, 2, 4 
 This condition has been reported to affect 4% of men and 2% of women aged 50 
years or older. 2 Estimates of the effect on the middle age population, who may be 
asymptomatic and therefore undiagnosed, are as high as 30%.  5 Almost 80% of these 
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undiagnosed cases are likely to be apneas that are of the moderate to severe forms. 2, 4-6 
Postmenopausal women are determined to be at greater risk for development than those 
that are premenopausal and individuals of African American descent are more likely to 
develop the syndrome at an earlier age than are Caucasians. 7  
Those who are at greatest risk for developing the syndrome are characterized as being 
male, obese and aged 65 or older. 2 Studies indicate that body weight is by far the greatest 
contributing factor and that a 10% gain in body mass increases one’s risk for developing 
OSA by six times. 8 It has been suggested that the mechanism for the age- and weight- 
related increase in incidence is derived from anatomic changes surrounding the pharynx, 
such as deposition of fat in the parapharyngeal area and lengthening of the soft palate. 5  
There are a number of skeletal and soft tissue anatomical variations that predispose a 
person to OSA. Having a maxilla or mandible that is retropositioned, enlarged 
parapharyngeal fat pads, thick lateral parapharyngeal musculature, an enlarged soft 
palate, enlarged tongue, or a narrow posterior airway space can lead to the development 
of both apneas and hypopneas.  2, 9-11 
Neuromuscular factors are also important in the development of OSA. The pharynx 
does not have skeletal support and is essentially a collapsible column, which must resist 
numerous stresses during speech, respiration and swallowing. Maintenance of the airway 
is achieved by tonic and phasic contractions of the pharyngeal dilator muscles. It has 
been observed that patients who suffer from OSA have hyperactive muscles during 
wakefulness to compensate for poor pharyngeal anatomy; however, during sleep the tone 
in these muscles is eliminated as reflex mechanisms from both chemoreceptors and 
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mechanoreceptors are reduced during rapid eye movement (REM) sleep, contributing to 
airway collapse. 2  
The size and position of the tongue are also influential. When awake and in a supine 
position, the tongue falls posteriorly. Normally, this is counteracted by the anterior pull of 
the genioglossus muscle. However, during REM sleep, the genioglossus also loses tone 
and allows the tongue to fall to a posterior position of obstruction. 1, 2 
Clinical features of OSA typically include snoring, snorting, gasping and choking 
with increased likelihood of repeated awakenings and insomnia. 2 Nocturia, chronic 
fatigue, daytime sleepiness and frequency of falling asleep during daytime activities are 
also common with the severity of symptoms increasing with increased body mass and 
age. Those who are afflicted may also experience morning headaches, dry mouth, chronic 
fatigue syndrome, fibromyalgia, irritable bowel syndrome, and migraine headaches. 2, 12 
There is also research indicating that the risk of motor vehicle accidents involving OSA 
patients is 1.3 to 7 times that of the national average. 1, 2, 13 
If left untreated, these symptoms may have a life threatening impact and are linked to 
the development of hypertension, coronary artery disease, stroke, depression, diabetes 
and glaucoma. 1, 14 Studies estimate that daytime sleepiness results in loss of productivity 
valued at $150 billion annually in addition to another $48 billion in medical costs related 
to motor vehicle accidents (American research data). 15 
OSA diagnosis is done in a clinical setting by obtaining a full medical history, 
including a subjective self-assessment via the Epworth Sleepiness Scale (ESS), physical 
exam, imaging studies and polysomnography. The Epworth Sleepiness Scale (Appendix 
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I) is a written questionnaire that asks for a subjective ranking of eight situations to 
determine a score out of a possible 24 points to assess the patient’s perceived level of 
sleepiness. 16 This test can be used both to assess pre-treatment sleepiness and to assess if 
the patient believes that improvement has been achieved during or after treatment. 
 Polysomnography involves the use of an electroencephalogram, electrooculogram, 
electromyogram, electrocardiogram, pulse oxymetry, respiratory inductance 
plethysmography, airflow measurement, recordings of body movement via infrared 
imaging and microphone measurements of snoring. It is considered the “gold standard” 
of analysis when diagnosing sleep apnea. 1, 2, 17 
Treatment options for obstructive sleep apnea involve both non-surgical and surgical 
management. Non-surgical approaches include loss of excessive body weight, fabrication 
of oral appliances and the use of continuous positive airway pressure (CPAP). Removing 
excess body fat can have a major impact on the reduction of OSA symptoms. Losing 
mass equivalent to 10.7 kilograms was correlated with a decreased AHI of 40% in 
patients who had been categorized as having mild OSA. 18-20 
Oral appliances can be used successfully by patients with mild to moderate OSA. 
These appliances are designed to either retain the tongue or reposition the mandible. 
Patients who are edentulous or suffer from macroglossia can utilize tongue-retaining 
appliances. They act to position the tongue anteriorly via negative pressure. The 
mandibular repositioning devices move the mandible forward thereby repositioning the 
attached musculature anteriorly, which increases the dimensions of the airway. Success 
of these appliances is dependent upon design and patient compliance. 20 
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CPAP is recognized as the most effective non-surgical method of managing OSA. 
This treatment places a constant pressure along the upper airway during breathing. It 
causes enlargement of the lateral pharyngeal walls and supports the tone of the dilator 
muscles, which in turn reduces the likelihood of collapse. The success rate of CPAP has 
been estimated at up to 78% with patients achieving increased cardiac output, decreased 
systemic vascular resistance, reduced cardiovascular mortality, increased alertness and 
improved daytime functioning. 15 Compliance however can be anywhere from 50-89% as 
patients complain of dry mouth, conjunctivitis, rhinorrhea, skin irritations, pressure sores, 
nasal congestion, epistaxis, claustrophobia and anxiety. 20, 21  
Phase I surgical procedures are considered site specific. These include nasal surgery 
(septoplasty or turbinectomy) to improve airway intake, surgery on the tongue to reduce 
the soft tissue volume thereby reducing airway blockage, and uvulopalatalpharyngoplasty 
(UPPP) to remove soft tissue in the oropharynx. Of these procedures, 
uvulopalatopharyngoplasty is the most common and involves adenoidectomy, 
tonsillectomy, and uvulectomy along with excision of redundant lateral pharyngeal wall 
mucosa. 1, 20 
The primary goal of the UPPP procedure is to shorten the palate, which results in 
increased airway dimension. Complications of the surgery may include changes in voice 
(nasal tone), dysphagia, nasal reflux and velopharyngeal insufficiency. 1, 21 Studies 
indicate that improvement is seen in as few as 50% of cases and this already poor 
prognosis may fall to 35% after four years. 21 The procedure is described as being painful 
with an extended recovery time. Goodday 22 reports that only one out of 14 patients that 
had the UPPP surgery would undergo the procedure again due to the painful recovery. 22 
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Perhaps the most significant reason for the poor success of the UPPP surgery lies in 
the location of the obstruction site(s) in the apnea patients. Rama et al. 23 studied available 
research published between 1980 and 2002 to determine the most common sites of 
obstruction in patients with obstructive sleep apnea. The authors note a variety of 
techniques utilized to identify the sites including nasopharyngoscopy, fluoroscopy, 
pressure measurements, CT scanning, and MRI. The search identified that the most 
common site of obstruction was at the level of the oropharynx with extension to the 
laryngopharynx also observed. However, in more recent studies it has been reported that 
multiple sites of obstruction were present. 23 Therefore a possible explanation for why the 
UPPP procedure has such a poor chance of success is that it targets only one specific site, 
and that area is not known to be one of the primary sources of obstruction. 22, 23 
Phase II surgical treatments include maxillomandibular advancement (MMA), 
tracheostomy and bariatric surgery. Bariatric surgery is used to facilitate weight loss to 
decrease sites of obstruction whereas tracheostomy is reserved as an emergency, life-
saving surgery for those patients who have not had success with other treatments. 20 
Tracheostomy can be a very successful treatment but the quality of life for the patients 
after surgery is questionable. In contrast, the quality of life is greatly improved with the 
use of MMA surgery, which has rapidly become one of the most sought after surgical 
treatments for those afflicted with obstructive sleep apnea. 1, 2, 6, 17, 20 
MMA surgery may be referred to as a telegnathic (lengthening of the jaws) surgery as 
opposed to orthognathic surgery (straightening of the jaws) and some patients may opt to 
forego the additional orthodontic treatment traditionally carried out with most 
orthognathic procedures. Telegnathic MMA surgery involves the advancement of the 
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maxilla, mandible, genial tubercles and hyoid, which results in a surgically stable 
enlargement of the posterior airway. Kuo et al 24 first used this surgical technique to 
address sleep apnea in 1979 as an alternative to tracheostomy in the most severely 
affected patients.  
Most orthognathic patients are young and otherwise healthy whereas the average 
OSA patient undergoing telegnathic MMA is likely to be older with additional 
dental/periodontal concerns as well as excess body weight, hypertension, intellectual and 
physical impairment, erectile dysfunction and depression. 25 Therefore the surgical 
management of OSA patients can be more challenging than the typical orthognathic 
patient. 17 
The rationale of MMA surgery is to increase both the lateral and the antero-posterior 
dimensions of the airway at all levels. At the same time, tension and tone of the 
suprahyoid and velopharyngeal musculature are improved due to movement of the hyoid 
to a more anterior and superior position. 26 These MMA movements are ideal to 
counteract the physiological problems identified by Gungor et al. 27 who recognized OSA 
patients as having significantly reduced mid-face length and inferiorly placed hyoid 
bones in conjunction with smaller airway dimensions when compared to controls.  
The success of MMA surgery has been repeatedly demonstrated using a variety of 
study designs. 28-34 Abramson et al. 35 reported on three-dimensional computed 
tomographic airway analysis of OSA patients that had undergone MMA treatment. This 
retrospective cohort study compared pre-treatment and post-treatment three-dimensional 
computed tomography (CT) scans from the hard palate to the base of the epiglottis. All 
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subjects underwent MMA surgery including genial tubercle advancement (GTA). The 
results of the comparison of the 3D scans demonstrated that the MMA and GTA 
treatments provided significant increases in antero-posterior and lateral airway diameter, 
increased airway volume, increased surface area, and greater uniformity in airway shape. 
In addition, subjects reported decreased daytime sleepiness, reduced fatigue, less snoring 
and improvements in memory. 35  
Ronchi et al. 21 postulated that the use of MMA could be as effective in patients 
without any skeletal anomalies as it was in those patients that did have a craniofacial 
anomaly. Two groups with differing skeletal patterns were evaluated before and after 
surgery. The first group had severe OSA as well as maxillomandibular hypoplasia. Group 
II also had severe OSA but did not have maxillomandibular hypoplasia or deformity. The 
final analysis included the apnea hypopnea index (AHI), posterior airway space (PAS), 
SNA and SNB angles, Epworth sleepiness scale, body mass index and subjective 
standardized questionnaire regarding esthetic appearance.  After statistical evaluation, it 
was noted that the results of both groups were comparable and included significant 
improvements in OSA symptoms along with remission of subjective symptoms as 
recorded by evaluation of the Epworth Sleepiness Scale. Thus, the authors concluded that 
MMA surgery could be encouraged for use in all patients suffering from OSA, not just 
those who could also benefit from improving adjacent skeletal deformity. 21 
Prinsell 15 published an extensive literature review on the use of MMA for primary 
and secondary telegnathic surgery in 2012. The purpose of the review was to establish the 
roll, surgical doctrines, and efficacy of primary MMA treatment (when MMA surgery 
was the first surgical treatment rendered to the patient) and secondary MMA treatment 
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(when other surgical treatment(s) had been undertaken prior to the MMA procedure). 
Surgical treatments such as distraction osteogenesis, tracheostomy, uni-level procedures 
(except for UPPP) and pediatric surgeries were excluded. AHI data from all cited cases 
were tabulated to calculate a mean percentage reduction in AHI. It was noted that a true 
definition of treatment success was not universally accepted at the time of publication. 
However traditional success rates, such as AHI reduction of at least 50% and/or a 
reduction to below a score of 20, was an acceptable benchmark. 15 MMA was separated 
from other multilevel operations and divided into four categories including primary 
MMA, primary MMA with extra-pharyngeal procedures, primary MMA with intra-
pharyngeal procedures, and secondary MMA. Additional recorded data included lowest 
arterial oxyhemoglobin saturation levels (LSAT), blood pressure, Epworth sleepiness 
scale scores, length of hospital stays, and lateral cephalometric analysis. 
The results of the review showed a mean reduction in AHI of 92.1% for primary 
MMA with extra-pharyngeal procedures, 88.4% for primary MMA and 86.6% for 
secondary MMA surgery. A 79.4% success rate was observed for MMA with intra-
pharyngeal procedures and only 53% success was determined for non-MMA multilevel 
surgery. Uvulopalatopharyngoplasty had the poorest prognosis with only 31.3% of 
surgeries meeting the defined expectations of success. The conclusions from this 
literature review stress that regardless of whether or not MMA surgery is applied as a 
primary or secondary surgery, it is highly therapeutic in comparison to non-MMA 
procedures. However, the authors caution that a definition for long-term success of MMA 
surgery has yet to be identified and that more research in this area is desired. 15 
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Research by Riley et al. 36 attempted to address the lack of long-term data available. 
Their publication studied outcome data of forty patients who underwent soft tissue and 
skeletal surgery. Evaluation methods included polysomnography, respiratory disturbance 
index (RDI), oxygen desaturation, body mass index, quality of life assessments, 
roentgenograhic analysis and surgical complications (RDI is defined as including apneas, 
hypopneas and any respiratory event-related arousals and is sometimes reported in lieu of 
AHI). The mean follow up was 50.7 months. They determined that 36 of the 40 patients 
displayed long-term clinical success. They also noted that a positive correlation was 
found between the amount of skeletal advancement and the likelihood of successful 
clinical outcome. 36 
Another long-term outcome study was completed by Jaspers et al. 37 The sample size 
was small, consisting of only 6 patients, however, the authors were able to complete an 
eight year follow up study on OSA patients who had undergone MMA surgery. Records 
were obtained for ESS, polysomnography and AHI. Six-month post-operative figures 
showed significant mean reductions in AHI, and ESS scores. At the eight-year follow-up, 
there had been only one patient with significant relapse. This patient still had a reduced 
ESS score, but his AHI was back up to 43 episodes per hour. Two other patients also had 
AHI values above 5, indicative of mild OSA. The authors recognized that the sample size 
was small, but cite that the mean statistical improvements were encouraging. 37  
Improved quality of life is a key goal of surgical treatment. Therefore measurement of 
treatment success should also include the patient’s subjective opinion of the surgical 
result. As such, research was done by Robertson et al. 38 via a patient questionnaire that 
included the Epworth Sleepiness Scale. Patients who had undergone MMA surgery for 
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OSA were questioned an average of 31.8 months after surgery and their recorded 
opinions demonstrated that daytime sleepiness, snoring, and witnessed apnea events were 
significantly reduced with 90% indicating that they would undergo the surgery again and 
100% would recommend the treatment to other sufferers of OSA. Of these patients, 70% 
had achieved an AHI of less than 10 postoperatively. 38 
A patient-centered quality of life study was done by Lye et al. 39 In addition to 
correlating findings from polysomnography and physical examinations, they used the 
functional outcomes of sleep questionnaire (FOSQ) developed by Weaver et al. 40 The 
group emphasized that quality of life in clinical medicine was often neglected and the aim 
of their study was to assess quality of life in patients undergoing MMA surgery. All 
patients had tried and failed to be able to use CPAP therapy prior to MMA. Pre-operative 
functional outcomes of sleep questionnaires were completed and compared to post-
surgery FOSQ answers. The improvement in FOSQ scores was statistically significant for 
all domains including general productivity, social outcomes, activity level, intimacy and 
sex. 39 The group encouraged the use of FOSQ for all surgical-based treatment in the 
assessment of patient satisfaction.  
Relative safety must be considered with any surgical procedure. Panula et al. 41 
reviewed 655 consecutive orthognathic surgeries for complications and problems. During 
a 13-year period, 655 MMA patients in Finland were observed for surgical complications. 
The patients were examined one week post-op, followed through their orthodontic 
treatment, and then again seen for a one-year post-operative assessment. There were 
some significant surgical concerns including 12% of patients requiring blood transfusions 
(usually red blood cells only), and one patient who had major bleeding from the 
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maxillary artery. Twelve patients had “bad splits” (referring to the bilateral sagittal split 
osteotomy of the mandible) and eleven had tears or cuts to the inferior alveolar nerve. 
Sixteen patients required re-operations due to loose screws/plates and severe post-op 
bleeding or swelling was observed in six patients. Five patients suffered from temporary 
localized acne and ten teeth were injured/damaged when struck by a bur during 
osteotomy. The most common problem was neurosensory injury involving the inferior 
alveolar nerve, which was mild in 32% of cases, and severe in only 3% of those affected. 
The most serious complication was severe bleeding. However, there were no deaths, no 
tooth loss, or loss of any bony segments. The authors concluded that orthognathic surgery 
is safe with severe complications being exceedingly rare. 41 
Obstructive sleep apnea has become an ever-increasing problem in North American 
society as the incidence of obesity increases and diagnostic technology becomes more 
advanced and readily available. An increasing financial burden to society combined with 
the debilitating health risks affecting those who are afflicted has led to increased interest 
in effective treatment strategies. The use of maxillomandibular advancement surgery has 
been proven to be a surgically stable approach when addressing the primary sites of 
obstruction found in OSA patients. The current literature has demonstrated that MMA 
has the potential to be an exceptionally effective surgical treatment method and should be 
considered a primary surgical technique for treatment of this debilitating disorder. 15, 22, 25, 
42 It is also one of the few curative treatments available for this pathology. However, 
further studies are required to confirm the probability of success of this surgical 
technique, and to ascertain the effect of various patient and surgical variables on this 
success rate. 
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The use of MMA as a surgical technique to treat OSA has been performed at the 
University of Western Ontario (UWO) for over 15 years. However, there has never been 
a retrospective analysis to determine the level of treatment success. Therefore, in an 
effort to further contribute to the current body of evidence, the purpose of this study was 
to evaluate the outcome of MMA surgery at UWO in patients suffering from obstructive 
sleep apnea syndrome. In addition, the authors sought to identify any pre or post-surgical 
parameters that might be predictive of MMA treatment success. 
14 
 
Materials and Methods 
Study Sample 
 This study was a retrospective cohort analysis. The data for this study was 
collected from the charts of patients who underwent maxillomandibular advancement 
surgery for the treatment of obstructive sleep apnea at the University of Western Ontario 
between the years 2002 and 2013. Patient charts were obtained from the London Health 
Sciences Centre Division of Oral and Maxillofacial Surgery at University Hospital, which 
is a teaching hospital affiliated with UWO. Ethics approval was obtained from the Health 
Sciences Research Ethics Board (HSREB), which manages the approval and monitoring 
of all research at the University of Western Ontario and its affiliated hospitals (Health 
Sciences REB File Number 104784 and Lawson Health Research Institute Approval 
Number R-14-047; Appendix II). 
 Subjects were chosen retrospectively by selecting consecutively treated patients 
who fulfilled the following inclusion criteria:  
1) Diagnosis of obstructive sleep apnea syndrome (OSAS) by a sleep physician 
based on the patient’s polysomnography results from an overnight sleep study  
2) Treatment via maxillomandibular advancement surgery by the oral and 
maxillofacial surgeon on the Dental Sleep Apnea Team at London Health 
Sciences Centre (Dr. M. Shimizu) 
3) Completion and availability of both a pre-surgical and post-surgical overnight 
sleep study (polysomnography), which included records of the patient’s apnea-
hypopnea index (AHI) scores and Epworth Sleepiness Scale (ESS) scores. 
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4) Good quality pre-surgical and post-surgical lateral cephalometric radiographs 
 The original sample size consisted of 32 patients (15 males, 17 females) collected 
from the records of Dr. Shimizu at the Department of Oral and Maxillofacial Surgery, 
London Health Sciences Centre. After scrutinizing the records of the original sample and 
applying the inclusion criteria, 10 patients (31.3%) were rejected from the study due to 
incomplete records, leaving 22 patients (11 females, 11 males) that were accepted as the 
sample population. 
Surgical Procedure 
 All lateral cephalometric radiographs were evaluated via the Delaire analysis 41, 42 
to determine the direction and amount of surgical movement desired for each patient. The 
maxilla was sectioned at the level of Le Fort I, advanced according to the treatment 
analysis via a pre-fabricated splint and fixated with plates and screws. Maxillomandibular 
advancement included bilateral sagittal split osteotomy of the mandible in the posterior 
body, angle and inferior ramus. The proximal segment (including condyles) was left in 
the original seated position, while the distal segment (alveolar bone and teeth with the 
body of the mandible) was advanced into a position, which has been pre-determined and 
captured, via an occlusal splint. The distal segment was then fixated with bicortical 
screws and/or miniplates and screws. 43 An additional osseous genioplasty procedure was 
performed on some subjects to allow for even greater advancement of the genial tubercles 
and adjacent musculature (geniohyoid, genioglossis, mylohyoid and digastric). 43  
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Data Collection 
The following data was recorded from patient charts: 
1) Pre-surgical and post-surgical apnea-hypopnea index scores (recorded during 
overnight sleep studies via polysomnography) 
2) Pre-surgical and post-surgical body mass index (BMI) scores 
3) Pre-surgical and post-surgical Epworth Sleepiness Scale (ESS) scores 
4) Pre-surgical and post-surgical radiographic films (lateral cephalograms) digitally 
scanned into Dolphin® imaging software (Version 11.7) 
5) Estimated blood loss during surgery and any associated intra or post-surgical 
sequelae and complications 
1) Apnea-Hypopnea Index (AHI) 
 AHI scores were recorded from the pre and post-surgical overnight sleep studies. 
These sleep studies were completed by the patients prior to being referred for a consult 
for surgical treatment on average 49.3 (+/-27.1) months prior to MMA and then again 
after completion of treatment with a mean follow up period of 15.7 (+/-9.4) months after 
MMA. Each subject’s AHI scores were recorded and indexed into the following 
categories 15:  
 AHI Scores below 5 = Normal levels of sleep (below threshold for OSA) 
 AHI Scores of 5-14 = Mild forms of sleep apnea 
 AHI Scores of 15-29 = Moderate sleep apnea 
17 
 
 AHI Scores greater than or equal to 30 = Severe form of sleep apnea.  
 Surgical treatment was considered successful if the pre-surgical AHI score was 
reduced post-surgically to a score below 15 and/or an overall reduction of the pre-
surgical AHI score by 50% or greater. A reduction of the AHI score to a value of less 
than 5 was indicative of the surgical treatment having resulted in a cure of that patient’s 
obstructive sleep apnea. The difference between pre- and post-surgical AHI values was 
reported both numerically and as a percentage change.  
 
2) Body Mass Index (BMI) 
 BMI = weight (kg) / height 2 (m 2) 
Pre-surgical and post-surgical body mass index scores were recorded and classified into 
the following 3 categories according to the Health Canada Body Mass Index 
Nomogram44: 
  BMI 18.50 – 24.99 = Healthy Weight 
  BMI 25.00 – 29.99 = Overweight 
  BMI 30.00 or greater = Obese 
Change in BMI was also calculated as this is known to be a factor in severity of 
obstructive sleep apnea. 8 
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3) Epworth Sleepiness Scale 
 Pre-surgical and post-surgical Epworth Sleepiness Scale scores were recorded 
from patient questionnaires and classified according to the following established 
categories  42: 
  Score of 0 – 9 = Normal (Patient is getting sufficient sleep or has an  
      acceptable amount of daytime sleepiness) 
  Score of 10 or greater = Excessive (Patient exhibits excessive/abnormally  
      high levels of daytime sleepiness) 
 Pre and post-surgical scores were examined for changes and as evidence for a 
subjective evaluation of treatment success. 
 
4) Radiographic Analysis 
 All cephalometric images were taken at London Health Sciences Centre on the 
same cephalostat (Siemans Orthophos O.P, Salzburg Germany). The protocol for 
capturing lateral cephalometric images included positioning the patient into the 
cephalostat with the sagittal plane of the head upright and parallel to the film and the 
Frankfurt plane parallel to the horizontal. The horizontal X-ray beam was positioned 
perpendicular to the sagittal plane and the film. The patients were directed to swallow 
and keep their tongue positioned at the roof of the mouth immediately prior to 
radiographic exposure.  
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 Two lateral cephalometric radiographs were analyzed from each patient chart. 
The pre-surgical lateral cephalogram was taken within one week prior to surgery. The 
post-surgical lateral cephalogram was taken at the patient’s first post-operative 
assessment, which was approximately one week later, and prior to any post-surgical 
orthodontic treatment being initiated (Appendix III). All radiographs were scanned into 
Dolphin ® 11.7 imaging software (Dolphin Imaging Version 11.7.05.66, Chatsworth, CA) 
via digital scanner (Epson Expression 1680, Seiko Epson Corporation Markham, ON). 
 A custom cephalometric analysis was constructed in Dolphin® 11.7 imaging and 
used to trace all cephalograms in this study (Figure 1). The custom analysis used both 
linear and angular measurements (Figures 2 and 3 respectively).  
 A horizontal reference plane was constructed by subtracting 7 degrees from Sella-
Nasion (SN-7°) and passing through Sella. This constructed Frankfurt horizontal line was 
utilized as the X-axis. A line running 90° perpendicular to this constructed horizontal 
line, that also passed through Sella point, was used as the Y-axis and referred to as Sella-
vertical (Sv). Sella-vertical was used as the vertical reference line to calculate changes in 
horizontal surgical movements (Figure 2).  
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Three linear measurements were used in the radiographic analysis (Figures 1 and 2).  
 1) Inferior Airway Space (IAS): A measurement taken at the most narrow point 
 in the inferior airway space of the oropharynx. The distance from the posterior 
 wall of the oropharynx, labelled posterior inferior airway (PIA), to  the base of the 
 tongue, labelled anterior inferior airway (AIA) was recorded (all measurements 
 in millimetres). 
 2) Sella-vertical to Incisor superiorus (Sv-Is): A linear measurement taken on the 
 horizontal plane from Sella-vertical to the incisor superiorus (incisal tip of upper 
 incisor) representing the surgical movement of the maxilla. Measurement was 
 made in millimeters (mm).  
 3) Sella-vertical to Incisor inferiorus (Sv-Ii): A linear measurement taken on the 
 horizontal plane from Sella-vertical to the incisor inferiorus (incisal tip of lower 
 incisor) representing the surgical movement of the mandible. Measurement was 
 made in millimeters (mm). 
 The use of Sv-Is (maxillary movement) and Sv-Ii (mandibular movement) to 
measure linear skeletal tissue movements was indicated due to difficulty in locating 
skeletal landmarks (A-point and B-point) in the post-surgical radiographs where the 
placement of surgical plates and screws may have distorted or covered the location of 
these points. This was deemed acceptable as no orthodontic movement occurred in the 
time period between the pre and post-surgical cephalograms. 
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Three angular measurements were also used in the radiographic analysis (Figure 3).  
 1) Sella-Nasion-A-point (SNA): Position of maxilla in reference to the cranial 
 base. Measured in degrees.  
 2) Sella-Nasion-B-Point (SNB): Position of mandible in reference to the cranial 
 base. Measured in degrees. 
 3) A-point-Nasion-B-point (ANB): Position of maxilla in reference to the position 
 of the mandible. Measured in degrees. 
These three angular measurements were utilized to categorize the skeletal patterns of the 
patient population prior to surgery. 
5) Estimated Blood Loss: 
 Surgical and post-surgical treatment notes were reviewed to gather the estimated 
volume of blood loss per surgical procedure and identify the development of any 
surgically related sequelae. Mean blood loss was calculated for the patient population and 
any intra or post-surgical complications were recorded. 
Statistical Methods 
 Data analysis was completed using SPSS statistical software program (Released 
2013. IBM SPSS Statistics for Windows, Version 22.0. Armonk, NY: IBM Corp). 
Descriptive statistics were calculated for all study variables before and after surgery as 
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well as any changes between them. The assumption of normality for statistical tests was 
assessed graphically. Paired t-tests were utilized to detect statistically significant changes 
between pre and post-surgical continuous variables. Fisher’s exact tests were utilized to 
assess the differences between successful and failure groups with regards to categorical 
predictor variables. An independent t-test was utilized to assess differences between 
successful and failure groups with regards to continuous predictor variables. The 
relationship between the pre and post-surgical change in AHI versus the change in ESS, 
BMI, IAS, Sv-Is and Sv-Ii was determined by calculating Pearson’s product-moment 
correlation coefficient (r). Statistical significance for all tests was set at a P-value < .05. 
 Measurement errors in tracing and digitizing were assessed by re-tracing and re-
measuring all 22 lateral cephalograms and re-digitizing them approximately three weeks 
later. All tracings and re-tracing were done by the same researcher. The formula of 
Dahlberg 45 was used to calculate the method of error. Measurement error and 
reproducibility of measurements were calculated (Appendix IV). In this study, a 
reproducibility of at least 90% was considered to be acceptable. 45  
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Results 
Radiographic Reproducibility and Error Analysis  
 The measurement error and reproducibility of cephalometric variables are shown 
in Appendix IV. The Dahlberg reproducibility error ranged from 0.91 to 0.96. These 
values met the minimum acceptable limit of 0.90. 45 The measurement errors for the linear 
measurements ranged from 0.41 mm to 1.06 mm, and for angular measurements the 
range was 0.50 to 0.98 degrees.  
Patient Demographics  
 Of the 22 patients who met the criteria for inclusion, 11 (50.0%) were female and 
11 (50.0%) were male (Table 1). The average age at the time of surgery was 44.0 (+/-
13.9) years with a range from 16.0 to 71.4 years. Surgeries were performed between 
January of 2002 and September of 2013. Orthodontic treatment (Ortho) was initiated 
prior to surgery in 16 of 22 (72.7%) patients. 
 
Subjects 
(N=22) 
Age 
(Years) 
Male  
 
Female  
 
Mean 44.0 11/22 11/22 
Range 16.0-71.4 
  
S.D. 13.9 
  
Table 1. Patient Demographics including age, number of males, and number of females 
in sample.  
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 The mean pre-surgical BMI of all patients was calculated to be 28.2 (+/- 4.2) with 
a range of 19.0 to 36.4 (Table 2). There was a mean post-surgical BMI of 29.2 (+/- 5.4) 
with a range of 19.2 to 38.7. Therefore the average change in BMI for the entire patient 
population was an increase of 1.0 (+/-3.2) with a range in BMI change of -3.1 to 9.5. The 
change between pre- and post-surgical BMI was not statistically significant (P >.05). 
Appendix V contains numeric and categorical BMI data for all patients. 
Table 2. Data for pre-surgical body mass index (Pre-BMI), post-surgical body mass 
index (Post-BMI), change in body mass index (BMI Change), percent change (% 
Change) and P-value between pre and post-surgical BMI scores. 
 
Success of Treatment 
 Prior to surgery, the mean AHI score was 48.4 (+/-31.3) episodes per hour with a 
range of 11.5 to 120.2 (Table 3). After surgery, the overnight sleep studies produced a 
mean AHI score of 14.0 (+/-15.0) events per hour with a range of 0.2 to 59.4. This 
indicated a mean reduction in the AHI of 34.3 (+/-29.4) episodes per hour, which 
translated to a 67.9% mean reduction in AHI post-surgically. For the entire patient 
population, the difference between pre and post-surgical AHI was found to be statistically 
significant (P<.001). (Appendices VI, VII, and VIII list all AHI values and OSA 
categories for both the successfully and unsuccessfully treated patients). 
Subjects)
)(N=22))
)
!
Pre%BMI!
!
Post%BMI!
!
BMI!
Change!
!
%!
Change!
P%Value!
!Mean! 28.2! 29.2! 1! 3.5 P=.165 
Range! 19.0.36.4! 19.2.38.7! (.3.1).(9.5)! (-8.6)-(33.9) 
 S.D.! 4.2! 5.4! 3.2! 11.5 
 !
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  Nineteen of the 22 (86.4%) patients met the criteria for successful treatment with 
a reduction of the AHI to levels below 15 and/or a 50% overall reduction in score. Of 
those patients who met the criteria for success, 8 of 22 (36.4%) had their AHI levels 
reduced below a score of 5, indicating a cure from the OSA identified pre-surgically. 
Table 3:  Pre-surgical apnea-hypopnea index scores (Pre-AHI), post-surgical apnea-
hypopnea scores (Post-AHI), change in score (AHI Change), percent change in score (% 
Change), and P-Value for difference between Pre-AHI and Post-AHI scores. 
 
 At time of data collection, 18 of 22 patient charts recorded both a pre- and post-
surgical Epworth Sleepiness Score questionnaire (Table 4). The mean pre-surgical 
Epworth Sleepiness Scale score was 11.6 (+/- 4.6) with a range of 3.0 to 18.0. The post-
surgical mean ESS score was reduced to 5.7 (+/- 3.5) with a range of 1.0 to 14.0. The 
reduction of the ESS scores after surgery was determined to be statistically significant 
from the pre-surgery scores (P<.001).  Appendix IX contains data for all pre-surgical and 
post-surgical Epworth Sleepiness Scores as well as categorical information. 
Subjects 
(N=18) Pre-ESS Post-ESS ESS Change P-Value 
Mean 11.6 5.7 -5.7 P<.001 
Range 3.0-18.0 1.0-14.0 (-14.0)-(10.0) 
 S.D. 4.6 3.5 5.5 
 
Table 4. Data for pre-surgical Epworth sleepiness scale scores (Pre-ESS), post-surgical 
Epworth sleepiness scale scores (Post-ESS), change in Epworth sleepiness scale scores 
(ESS Change), and P-Value between pre and post-surgical ESS scores. 
 
Subjects)
(N=)22)) Pre1AHI) Post1AHI) AHI)Change) %)Change)
P1Value)
Mean% 48.4% 14.0% +34.3% +67.9% P<.001%
Range% (11.5)+(120.2)% (0.2)+(59.4)% (+104.1)+(8.4)% (+99.3)+(46.2)% %
S.D.% 31.3% 15.0% 29.4% 39.1% %!
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Predictors of Treatment Success 
 
Table 5. The success and cure rates of Age, Gender, Genioplasty (Genio), Orthodontics 
(Ortho) and pre and post-surgical Epworth Sleepiness Scale scores (Pre-ESS, Post-ESS) 
were compared. None of these variables were statistically significant factors on treatment 
success or cure (P >.05).  
  
 Age 
 Median age of the patients in the study was calculated to be 45.5 years (Table 5). 
When those above and below the median age were compared to success and cure 
measures, no statistically significant difference could be found between either age group 
with regards to treatment success or cure (P >.05). 
  
Variable(
(
%(Success(
(86.4%)(
( (
%(Cure(
(36.4%)(
(Age$
(N=22)$
Above$45$
(N=11)$
Below$45$
(N=11)$
P4value$
$
Above$45$
(N=11)$
Below$45$
(N=11)$
P4value$
$
$
72.7$ 100.0$ .107$ 36.4$ 36.4$ .670$
Gender$
(N=22)$
M$
(N=11)$
F$
(N=11)$
P4value$
$
M$
(N=11)$
F$
(N=11)$
P4value$
$
$
81.8$ 90.9$ .534$ 27.3$ 45.5$ .375$
Genioplasty$
(N=22)$
Yes$
(N=13)$
No$
(N=9)$
P4Value$
$
Yes$
(N=13)$
No$
(9)$
P4value$
$
$
92.3$ 77.8$ .358$ 38.5$ 33.3$ .584$
Orthodontics$
(N=22)$
Yes$
(N=16)$
No$
(N=16)$
P4value$
$
Yes$
(N=16)$
No$
(N=16)$
P4Value$
$
$
87.5$ 83.3$ .636$ 43.8$ 16.7$ .255$
Pre4ESS$
(N=18)$
Normal$
(N=6)$
Excessive$
(N=12)$
P4Value$
$
Normal$
(N=6)$
Excessive$
(N=12)$
P4Value$
$
$
100.0$ 75.0$ .515$ 33.3$ 25.0$ .561$
Post4ESS$
(N=18)$
Normal$
(N=16)$
Excessive$
(N=2)$
P4Value$
$
Normal$
(N=16)$
Excessive$
(N=2)$
P4Value$
$
$
81.3$ 100.0$ .502$ 31.3$ 0.0$ .352$!
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Gender 
 There were 11 females (50.0%) and 11 males (50.0%) in the sample population of 
this study. For the female patients, 10 of 11 (90.9%) were treated successfully and 5 of 11 
(45.5%) met the standards for cure, whereas 9 of 11 (81.8%) males met the criteria for 
success and 3 of 11 (27.3%) could be categorized as cured after treatment (Table 5). No 
statistically significant association could be found between a patient’s gender and 
likelihood of success or cure (P>.05) 
 Genioplasty 
 Thirteen of the 22 (59.1%) patients in the study underwent the additional surgical 
step of functional genioplasty. Of the 13 patients who underwent the procedure, 12 
(92.3%) had success and 5 (38.5%) qualified as cured. In the non-genioplasty group, 7 
out of 9 (77.8%) were successfully treated and 3 of 9 (33.3%) were cured (Table 5). 
However, neither the genioplasty nor non-genioplasty group were statistically more likely 
to achieve success or cure (P >.05). 
 Orthodontics 
 During treatment 16 of 22 (72.7%) patients underwent orthodontics in addition to 
MMA surgery. For the orthodontic group, 14 of 16 (87.5%) had surgical success with 7 
of 16 (43.8%) being cured.  For the non-orthodontic group, 5 of 6 (83.3%) qualified for 
success and 1 (16.7%) for cure (Table 5). No statistical significance could be found for 
either the orthodontic or non-orthodontic treatment group in regard to likelihood of 
treatment success or cure (P >.05). 
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 Epworth Sleepiness Scale 
 The pre-surgical average self-reported score of the ESS was 11.6 (+/- 4.6), which 
included 6 of 18 (33.3%) patients scoring below 9 (normal), and 12 of 18 (66.6%) 
patients scoring above 9 (excessive). All 6 patients (100%) who had pre-surgical ESS 
scores in the normal category were observed to have met the criteria for success after 
treatment. Of those patients who had pre-surgical ESS scores in the excessive category, 9 
out of 12 (75.0%) also met the criteria for surgical success (Table 5). Two of the 6 
(33.3%) patients in the normal category and 3 of the 12 (25.0%) patients in the excessive 
category met the criteria for cure. No significant association was found between a 
subject’s pre-surgical ESS score and their likelihood of surgical success or cure (P >.05).  
 For the post-surgical ESS scores, 13 of 16 (81.3%) from the normal category and 
both of the 2 (100.0%) patients who were in the excessive category had surgical success 
while 5 of 16 (31.3%) of those in the normal category and 0 out of 2 in the excessive 
category achieved a cure (Table 5). No significant statistical association could be found 
between a subject’s post-surgical ESS score and treatment success or cure (P >.05). 
 The pre to post-treatment change in ESS was compared against the pre to post-
treatment change in AHI (Table 9). A mild negative correlation was detected (Appendix 
X). However there was no statistically significant relationship (r = -.461; P = .054). 
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Table 6. Variables in relation to treatment success and cure including: Pre-surgical BMI 
(Pre-BMI), Post-surgical BMI (Post-BMI), pre-surgical apnea-hypopnea index (Pre-
AHI), pre-surgical sella-nasion-A-point (Pre-SNA), pre-surgical sella-nasion-B-point 
(Pre-SNB), and pre-surgical A-point-nasion-B-point (ANB). Associated P-Values are 
reported. 
 
 Pre and Post-surgical BMI 
 When evaluating a patient’s pre-surgical BMI classification versus success of 
treatment, the healthy category had 2 of 3 (66.7%) successful with 1 of 3 (33.3%) 
meeting the standards for cure (Table 6). The overweight category had 11 of 13 (84.6%) 
successfully treated and 5 of 13 (38.5%) were cured. Of those in the obese category, 6 of 
6 (100%) were treated successfully and 2 of 6 (33.3%) met the criteria for cure. There 
was no statistical significance between a patient’s pre-surgical body mass index score and 
treatment success or cure (P >.05) 
!Variable!
!
%!Success!
(Total!=!86.4%)!
%!Cure!
(Total!=!36.4%)!
Pre;BMI!
(N=22)!
Healthy(
(N=3)(
Overweight(
(N=13)(
Obese(
(N=6)(
P9value(
(
Healthy(
(N=3)((
Overweight(
(N=13)(
Obese(
(N=6)(
P9Value(
(
!! 66.7( 84.6( 100.0( .280( 33.3( 38.5( 33.3( .970(
Post;BMI!
(N=22)!
Healthy(
(N=6)(
Overweight(
(N=7)(
Obese(
(N=9)( P9Value(
Healthy(
(N=6)(
Overweight(
(N=7)(
Obese(
(N=9)( P9Value(
!! 83.3( 71.4( 100.0( .154( 66.7( 28.6( 22.2( .188(
Pre;AHI!
(N=22)!
Mild(
(N=2)(
Moderate(
(N=6)(
Severe(
(N=14)(
P9Value(
(
Mild((
(N=2)(
Moderate(
(N=6)(
Severe(
(N=14)(
P9Value(
(
!! 100.0( 66.7( 92.9( .247( 100.0( 50.0( 21.4( .070(
Pre;SNA!
(N=22)!
Retro(
(N=8)(
Normal(
(N=4)(
Prog(
(N=10)(
P9value(
(
Retro(
(N=8)(
Normal(
(N=4)(
Prog(
(N=10)(
P9Value(
(
!! 75.0( 87.5( 90.0( .756( 50.0( 25.0( 40.0( .662(
Pre;SNB!
(N=22)!
Retro(
(N=12)(
Normal(
(N=10)( ((
P9Value(
(
Retro(
(N=12)(
Normal(
(N=10)( ((
P9Value(
(
!! 83.3( 90.0( (( .571( 41.7( 30.0( (( .454(
Pre;ANB!
(N=22)!
<7.7°(
(N=11)(
>(7.7°(
(N=11)(
(
P9Value(
(
<7.7°(
(N=11)(
>(7.7°(
(N=11)(
(
P9Value(
(
!( 81.8( 90.9(
(
1.0( 27.3( 45.5(
(
.156(!
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 After surgery, 6 patients were in the healthy BMI category and 5 of 6 (83.3%) 
were successfully treated with 4 of 6 (66.7%) having been cured. Of the 7 in the 
overweight category, 5 (71.4%) were successful and 2 (28.6%) were cured. The obese 
category increased to 9 patients with all 9 (100%) being successfully treated and 2 
(22.2%) being cured. There was no statistical significance between a patient’s post-
surgical BMI category and success of treatment or cure (P >.05).  
 The change in BMI was plotted against the change in AHI (Table 9) and a 
moderate negative correlation was detected (Appendix XI). This correlation was 
determined to be statistically significant (r = -.661; P= .001). 
  Pre-surgical AHI 
 Prior to surgery, 2 patients were classified as being in the mild category (AHI of 
5-15) for their apnea-hypopnea index scores (Table 6). Both of these patients met the 
standards for treatment success (100%) and cure (100%). Of the 6 patients in the 
moderate OSA category, 4 (66.7%) were successfully treated and 3 (50.0%) were cured. 
For the 14 patients in the severe category, 13 (92.9% were treated successfully and 3 
(21.4%) were cured. There was no statistical significance found between a patient’s pre-
surgical apnea-hypopnea index and treatment success or cure (P >.05).   
 Pre-Surgical SNA 
 The mean pre-surgical SNA for all patients was calculated to be 83.8 (+/-3.9) 
degrees, which is categorized as normal.  46 Pre-surgical SNA groups in Table 6 are 
reported as retrusive (retro), normal and protrusive (prog). In the group of patients where 
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SNA was in the normal (82 +/- 2°) category, 7 of 8 (87.5%) were successfully treated 
with 2 of 8 (25%) achieving cure. The retrusive (less than 80°) category had 3 of 4 (75%) 
successful and 2 of 4 (50%) who were cured while the protrusive (greater than 84°) 
category had a 90% (9 of 10) success rate with 4 of those (40%) achieving the criteria for 
cure. All pre-surgical SNA values are reported in Appendix XII. No statistical 
significance was found between the value of a patient’s pre-surgical SNA angular 
measurement and likelihood of successful treatment or cure outcome (P >.05). 
 Pre-surgical SNB 
 The mean value of the SNB for the entire sample was 76.5 (+/- 4.0) degrees, 
which is considered to be retrusive.  46 Pre-surgical SNB values in Table 6 are reported to 
be either retrusive (retro) or average (norm). Of the patients who had a retrusive SNB 
angle (pre-surgical value of less than 78°), 10 of 12 (83.3%) were treated successfully 
and 5 (41.7%) met the criteria for cure. In those patients who had average SNB values, 9 
out of 10 (90.0%) had treatment success with 3 (30.0%) achieving cure. All pre-surgical 
SNB values are reported in Appendix XII. No statistical significance was found between 
a patient’s pre-surgical SNB angle and the likelihood of treatment success or cure 
(P>.05). 
  
Pre-Surgical (ANB) 
 The median value of the entire group was 7.7°. Of the patients who were below 
the median ANB value, 9 out of 11 (81.8%) had successful treatment and 3 (27.3%) were 
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in the cure group (Table 6). For those above the median ANB value of 7.7°, 10 out of 11 
(90.9%) had successful treatment and 5 (45.5%) of them were classified as cured. All 
pre-surgical ANB values are reported in Appendix XII. There was no statistical 
significance found between pre-surgical ANB value and treatment success or cure (P > 
.05). 
  
 IAS 
 For the entire population, the pre-surgical inferior airway space (IAS) 
measurement had a mean of 8.1 (+/- 4.1) mm with a range of 2.7 to 19.2mm (All pre and 
post-surgical values for IAS are reported in Appendix XIII). Post-surgical IAS 
measurements averaged 14.6 (+/- 3.9) mm with a range of 9.3 to 20.1 mm. The average 
change from pre-surgery to post-surgery was 6.6 (+/-4.5) mm, which equated to a mean 
increase of 123.3% (Table 7). This change in IAS from pre-surgery to post-surgery was 
found to be statistically significant (P<.001).  
 
Table 7. Measurements of the inferior airway space including pre-surgical airway space 
(Pre-IAS), post-surgical airway space (Post-IAS), change in airway space (IAS Change), 
percent change in airway space (% Change), and P-Value. All measurements are in 
millimeters (mm). 
Subjects 
(N= 22) 
Pre-IAS 
(mm) 
Post-IAS 
(mm) 
IAS Change 
(mm) 
% Change P-Value 
Mean 8.1 14.6 6.6 123.3 P<.001 
Range 2.7-19.2 9.3-20.1 0.7-17.3 7.1-302.3  
S.D.  4.1 3.9 4.5 143.9  !
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 The average pre-surgical IAS measurement of only those patients who had 
surgical success was 8.3 (+/- 4.4) mm whereas those that did not have successful 
treatment had an average IAS measurement of 6.3 (+/-1.8) mm (Table 8). When the two 
group means were compared, there was no statistical significance between them 
regarding treatment success (P >.05). The pre-surgical mean of those who met the criteria 
for cure was 7.0 (+/-2.5) mm and 8.6 (+/- 4.8) mm for those who did not fulfill the 
criteria. The difference between these two means was also not statistically significant (P 
>.05).  
 
Table 8. Means, standard deviations, and P-values of pre-surgical inferior airway space 
(Pre-Surg IAS), post-surgical inferior airway space (Post-Surg IAS), maxillary horizontal 
movement (Sv-Is), and mandibular horizontal movement (Sv-Ii). No surgical variables 
were found to be statistically significant in relation to treatment success or cure (P >.05). 
 
 The average post-surgical IAS measurement of successfully treated patients was 
14.3 (+/- 3.6) mm and the unsuccessful patient mean measured 16.2 (+/- 6.4) mm while 
the mean post-surgical IAS measurement for the cure group was 12.6 (+/-2.5) mm and 
the non-cure group mean was 15.8(+/-4.2) mm. There was no statistically significant 
correlation between the mean post-surgical IAS measurement and likelihood of treatment 
success or cure (P>0.05). The mean amount of change in the AHI was compared to the 
Treatment(
Variable(
(N=22)(
Success(
(mm)(
Non7
success(
(mm)( P7Value(
Cure(
(mm)(
Non7Cure(
(mm)( P7value(
Pre7Surg(IAS( 8.3$(+/(4.4)$ 6.3(+/(1.8)$ .444$ 7.0(+/(2.5)$ 8.6(+/(4.8)$ .399$
Post7Surg(IAS( 14.3(+/(3.6)$ 16.2(+/(6.4)$ .466$ 12.6(+/(2.5)$ 15.8(+/(4.2)$ .058$
Sv7Is( 9.2(+/(3.6)$ 6.7(+/(5.1)$ .314$ 9.5(+/(3.8)$ 8.4(+/(3.9)$ .531$
Sv7Ii( 12.4(+/(4.5)$ 11.6(+/(4.6)$ .780$ 14.0(+/(5.8)$ 11.3(+/(3.4)$ .181$!
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mean amount of change in the IAS score (Table 9). No significant correlation could be 
drawn between the two variables (Appendix XIV, r = .079; P = .725).  
 
Table 9. The change in the apnea-hypopnea index score was compared to the change in 
the body mass index (BMI), change in Epworth sleepiness scale (ESS), change in inferior 
airway space (IAS), change in horizontal movement of the maxilla (Sv-Is), and change in 
horizontal movement of the mandible (Sv-Ii), (r and P-values are both reported). 
  
 Maxillary Movement (SV-Is) 
 For the entire population, the surgical movement of the maxilla (Sv-Is) on the 
horizontal plane had a mean of 8.8 (+/- 3.8) mm with a range of 0.9-16.4 mm. Patients 
who had successful treatment averaged an increase of 9.2 (+/- 3.6) mm, whereas patients 
who had unsuccessful treatment had an average increase of 6.7 (+/-5.1) mm after surgery 
(All pre and post-surgical Sv-Is values are reported in Appendix XV). Those that were 
cured had a mean movement of 9.5 (+/- 3.8) mm and those who were not cured averaged 
8.4 (+/- 3.9) mm (Table 8). No statistically significance was calculated between the 
amount of maxillary movement on the horizontal plane and likelihood of successful 
treatment or cure (P> .05). The change in AHI score and the change in maxillary 
movement (Sv-Is) were compared (Table 9) and there was no significant correlation 
(Appendix XVI, r = -.260; P= .242).  
!!!!AHI!Change!
Vs.!
!
BMI!*!
(N=22)!
ESS!
(N=18)!
IAS!
(N=22)!
Sv;Is!
(N=22)!
Sv;Ii!
(N=22)!
r!
!
!.661*! !.461! .079! !.260! !.176!
P;Value!
+
.001*+ .054+ .725+ .242+ .434+!
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 Manidibular Movement (Sv-Ii) 
 The surgical movement of the mandible (Sv-Ii) on the horizontal plane had a 
mean of 12.3 (+/- 4.4) mm among the entire patient population with a range of 5.0 to 23.3 
mm (all distances for mandibular advancement are reported in appendix XVII). Patients 
who experienced treatment success had an average movement of 12.4 (+/-4.5) mm of 
movement and those who did not meet the criteria of success had an average of 11.6 (+/- 
4.6) mm of movement (Table 8). Those who met the criteria for cure had a mean 
movement of 14.0 (+/- 5.8) and the non-cure group averaged 11.3 (+/-3.4). No statistical 
significance was found between the amount of mandibular movement (Sv-Ii) and 
treatment success or cure (P>.05). Table 9 contains data for comparison of the change in 
AHI and the change in horizontal advancement of the mandible (Sv-Ii).  No significant 
correlation was detected (Appendix XVIII, r = -.176; P = .434). 
 
 Surgical Blood Loss and Sequelae: 
 The amount of estimated blood loss (Table 10) during surgery was recorded in the 
surgical treatment notes to have an average of 386.4 (+/-114.6) cubic centimetres (cc). A 
complete list of significant medical conditions, estimated blood loss during surgery, and 
surgical-related complications is found in Appendix XIX. 
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 Table 10. Estimated blood loss during surgery (measured in cubic centimetres). 
 There were no deaths, no loss of bony segments, and no loss of teeth. Surgical 
sequelae included one patient who developed pneumonia requiring five days in hospital 
(full recovery), non-union of a Le Fort osteotomy which required a second surgery (full 
recovery), removal of a broken plate (no further treatment required, full recovery) and 
one patient required root canal therapy followed by internal bleaching on a central 
incisor.  
 
 
 
 
 
 
 
 
All Patients 
 
Estimated Blood Loss During Surgery 
(CC) 
Mean 386.4  
Range (200.0)-(750.0)  
S.D. 114.6  !
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Discussion  
 Patients who suffer from obstructive sleep apnea syndrome can develop serious 
medical conditions that have a negative effect on quality of life.  1, 13, 15 There are a variety 
of treatments currently being implemented for those who suffer from this condition 
including various surgical approaches. 1 The use of maxillomandibular advancement 
surgery has been proposed as the most effective craniofacial surgical treatment for OSA 
sufferers. 42 The purpose of this study was to evaluate the success of maxillomandibular 
advancement surgery at the University of Western Ontario when treating patients 
suffering from OSA and to identify if there were any demographic or treatment variables 
that had an effect on the success of treatment. 
 The definition of treatment success that was selected for use in this study was 
based upon the standards and precedents of recently published literature.  15, 25, 47 The 
majority of the MMA literature uses a definition of success that shows a post-operative 
AHI < 20 (or <15 or <10) and /or a 50% reduction.  15At present, there remain a variety of 
study methodologies and the literature indicates that there is no universally accepted 
definition of success when surgically treating OSA. 15 The definition utilized by this study 
(a post-surgical reduction of the AHI to a score below 15 and /or an overall AHI decrease 
of 50%), achieved a standard of having the patient’s OSA reduced to the level of mild 
sleep apnea (AHI between 5 and 14 episodes per hour) or below, where the symptoms 
and associated conditions are less severe. There is likely a benefit for patients treated 
with MMA surgery even when OSA is not completely cured. 42, 48 Li suggests that OSA is 
similar to other chronic illnesses in that complete elimination may not be possible and 
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therefore the goal of any treatment that is implemented is to control or improve the 
symptoms by reducing the severity of the syndrome. 49   
 The definition of a cure from OSA does appear to be universally accepted 
throughout the published literature and is indicated by an AHI level that is reduced to 
below 5 episodes per hour. This is the minimum number of apneas per hour required to 
qualify as having any form of sleep apnea. 2, 42 Therefore this definition of cure was 
utilized in the present study and is easily comparable to the current body of literature. 
 The results observed in this study, which included 19 of 22 patients (86.4%) 
achieving surgical success along with 8 of 22 patients (36.4%) achieving a cure from 
their OSA symptoms, are very similar to the levels of success that have been reported in 
the published literature. 11, 15, 22, 25, 42, 47, 49 Dekeister et al. 11 reported data on a retrospective 
study of 25 males with a mean age of 48.0 (+/-7.0) years. The mean pre-surgical BMI of 
the group was 28.0 (+/-3.4) and the mean apnea-hypopnea index was determined to be 
45.0 (+/-15.0) episodes per hour prior to MMA. After surgery, the success rate of the 
study was 84% with a cure rate of 48%.  
 Varghese et al. 50 completed research on 24 patients (75% male) with a mean age 
of 48.3 (+/-10.8) years who underwent MMA for treatment of OSA. All 24 patients had 
pre- and post-surgical AHI values recorded via overnight polysomnography with a pre-
surgical mean of 45.4 (+/- 26.4) and post-surgical mean of 7.8 (+/- 10.5). An 83% 
reduction in AHI was produced and the difference from pre- to post-surgical values was 
statistically significant. Only 18 patients had both pre- and post-surgical BMI values 
recorded and the difference in the BMI values was not statistically significant. The 
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Epworth Sleepiness Scale was completed before and after surgery by 14 of the 24 
patients with a mean pre-surgical ESS score of 13.6 (+/- 5.4) and a mean post-surgical 
ESS score of 8.8 (+/- 3.3), which equated to a 35% reduction in ESS score after surgery. 
In regards to success rate, this study showed 87.5% of patients had achieved an AHI 
reduction of 50% and/or an AHI score less than or equal to 20 events per hour. These 
results are very similar to those found in the present study.  
  Holty and Guilleminault  42 performed a systematic review and meta-analysis to 
estimate the clinical efficacy of treating obstructive sleep apnea with MMA surgery. 
After scrutinizing the literature they included 22 unique patient populations that were 
studied between 1989 and 2009. Among the 22 studies a total of 627 patients were 
observed with a range of study sample sizes from 2 patients to 175 patients with a mean 
of 28.5 patients per publication. The average success rate of all studies investigated was 
86.0% with an average cure rate of 43.2%. This reported level of success and cure was 
very comparable to the results achieved in this study.   
 There are a variety of methodologies among the current literature for assessing 
subjective, self-reported improvement in sleepiness.  Authors have used second-person 
reports of snoring and restlessness from spouses and family members, personalized 
patients questionnaires, the Functional Outcomes of Sleep Questionnaire and the Epworth 
Sleepiness Scale. 15, 22, 42 Patients involved in this retrospective study were given the 
Epworth Sleepiness Scale and the mean pre-surgical ESS score was 11.6 (+/- 4.6). The 
post-surgical mean ESS score was reduced to 5.7 (+/- 3.5). This represented a mean 
reduction in subjective levels of sleepiness of 37.8%. This post-surgical reduction level 
was comparable to that of Holty 42, which reported that patients who had completed the 
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Epworth Sleepiness Scale as part of their sleep studies had a mean pre-treatment score of 
13.2 (+/- 5.5) with post-treatment scores averaging 5.1(+/- 3.6).   
 Goodday 51 also showed comparable results in his study, which evaluated the 
subjective outcomes of 116 patients who underwent MMA surgery for OSA syndrome 
from 2000 to 2010. Preoperatively only 28% of patients scored below 10 (normal levels 
of sleep) on the Epworth Sleepiness Scale. After surgery 90% had reduced their ESS 
score to less than 10. In the present study, only 27.3% patients recorded a pre-surgical 
score of 10 or less on the ESS, whereas post-operatively 77.3% of patients had reduced 
their score down to the normal category. 
 Johns 52 reported that the Epworth Sleepiness scale is both reliable and consistent. 
However, it must be recognized that the ESS is the patient’s own subjective rendering of 
how they recall their levels of sleepiness at the time that they are reporting it. It would be 
expected that there might be multiple external factors that would affect ones recording of 
sleepiness levels on any given day. For example, some patients may be required by law to 
reduce their levels of sleepiness in order to maintain employment or to qualify for a 
drivers licence. In the present study, one patient (patient # 6, Appendix VII) had a post-
surgical AHI decrease of 90.5 episodes per hour, yet his reported ESS scores increased 
from 4 pre-surgically to 14 after surgery. This patient was suffering from bipolar disorder 
and was taking multiple psychoactive medications at the time of surgery. Perhaps the 
mood altering effect of the bipolar disorder may have had an influence on that patient’s 
reporting of sleepiness levels in either a positive or negative way.  
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  Interestingly, for the 3 patients in this study who did not meet the criteria for 
surgical success, there was a pre-surgical mean ESS score of 13.3 +/- 3.5 (excessive 
sleepiness) and a post-surgical mean of 5.0 +/-1 (normal levels of sleepiness). Therefore 
even though these 3 patients did not meet the AHI standard for successful treatment, they 
reported a mean subjective reduction in daytime sleepiness of 63.8%. Additionally, all 3 
of these unsuccessful patients had their reported amount of sleepiness reduced down to 
normal levels (ESS score of 9 or less), which may be indicative of a successful outcome 
from the patient’s perspective. 
 Some publications have reported finding treatment variables that have been 
predictive of surgical success. These variables included younger patient age, decreased 
pre-operative weight, greater maxillary advancement and greater increases in SNA and 
SNB after surgery.  42, 53 In the present study, multiple variables were examined for 
predictors of success, with the goal of determining what patient characteristics may be 
best suited for MMA surgery, and also which specific treatment protocols would enhance 
the surgical outcome. However, for all variables examined, no statistically significant 
associations were detected (P>.05). This is likely attributable to the limited sample size in 
this study (n = 22), and the even smaller sample size of the surgical failure group (n = 3), 
which decreases the power of the study and makes it difficult to detect a significant 
correlation between variables.  
 Patient gender was compared to the likelihood of treatment success and no 
statistical significance was found (P>.05). This is in agreement with previous studies that 
found no association between gender and treatment success. 25, 42 However, this study did 
provide a unique sample population, as 11 of the 22 patients (50.0%) that met the 
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inclusion criteria were female. Two systematic reviews reported the percentage of males 
in the studies that were included: the Stanford group  42 had a range of 65%-100% with an 
average of 88% male, while Pirklbauer et al.  25 had a range of 61.9%-100% and averaged 
86.3% males. Therefore, the present study appears to be unique in that it may be the first 
to have an equal population of male and female patients who have undergone MMA 
surgery to treat obstructive sleep apnea.  
 Mean age of the patients in this study was calculated to be 44.0 (+/- 13.9) years, 
which again was comparable to the mean age of the 22 studies reviewed by Holty40 that 
reported an average age of 44.4 (+/- 9.4) years. 42 Age was not found to be a predictor of 
treatment success in the present study (P>.05), however it is notable that the mean age of 
those patients who did have treatment success was 41.0 (+/-12.2) years, whereas the 
mean age of the unsuccessful patients was 63.1 (+/-7.9) years. Age was reported to be a 
predictor of success by Holty et al. 42 Their research indicated that patients who were 
younger at the time of their surgeries had an increased likelihood of successful MMA 
treatment.  
 Some patients in this study underwent two adjunctive procedures in addition to 
the MMA surgery. The first was orthodontic treatment, with or without extractions of 
teeth, to allow for maximal surgical movement. The second adjunctive procedure, a 
functional genioplasty, may be expected to further increase the volume of the airway as 
the genial tubercles and associated musculature (geniohyoid, mylohyoid, genioglossus, 
digastric) is pulled even further anteriorly than what is observed with mandibular 
advancement alone. This would be expected to increase the likelihood of maximizing the 
positive airway change. In the present study, neither the orthodontic nor genioplasty 
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procedures produced a greater likelihood of treatment success (P >.05), which is in 
agreement with the current literature where no studies found either of these procedures to 
be predictive of success. 
  The average body mass index (BMI) of patients in this study remained relatively 
constant. Pre-surgically the mean BMI was 28.2 (+/-4.2) and post-surgically the BMI 
average was very similar at 29.2 (+/- 5.4). There was no significant association found 
between a patient’s pre-surgical BMI or post-surgical BMI and likelihood of success 
(P>.05), which is contrary to findings in other studies that indicated a lower pre-surgical 
BMI could be a predictor of greater surgical success. 42 However, there was a small 
negative correlation (r = -.661) between the change in BMI and change in AHI that was 
not observed in other studies. This indicated that, as the patient’s BMI went up (gained 
weight after surgery), their AHI episodes decreased. This finding was unexpected and 
would warrant further study with a larger sample to determine if it could be used as a 
predictor of successful treatment. 
 The Epworth Sleepiness Scale was used in this study because it is the most widely 
used analysis to report excessive daytime sleepiness. 51 The ESS was used to divide the 
patients into those who had acceptable levels of sleepiness (scores of 9 and below) and 
those with excessive sleepiness (scores of 10 and above). Pre-surgical and post-surgical 
classifications were compared with treatment success and no statistically significant 
correlations were found (P>.05). Therefore the ESS scores from both pre- and post-
surgery were not predictors of success and this is consistent with other published 
research.  25, 42, 50 
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 The radiographic analysis in this study included measurements of the horizontal 
dimension of the Inferior Airway Space (IAS), linear hard tissue movements of the 
maxilla (Sv-Is) and mandible (Sv-Ii) and also calculations of the angular relationships of 
the maxilla to the cranial base (SNA), mandible to cranial base (SNB) and maxilla in 
reference to the mandible (ANB).  It should be recognized that, while lateral 
cephalometric radiographs are an excellent method of assessing hard tissue (skeletal) 
position, they are a static image of soft tissue that is dynamic in real time. Therefore 
using a lateral cephalometric image to trace/measure a soft tissue landmark, such as the 
inferior airway space, may have limitations. Measurements of soft tissues may change if 
taken at different time points or if taken with the patient in a different postural position. 
The measurements obtained from the radiographs can be used as part of a patient record 
to guide treatment and assess surgical results, but cannot be considered alone as 
diagnostic, and must to be corroborated with a polysomnography study and subjective 
self-assessment (ESS) in order to provide a diagnosis of OSA.  
 For the inferior airway space, neither the pre-surgical nor post-surgical mean 
values were shown to be predictors of treatment success (P >.05). This was consistent 
with the findings of other research. 25, 42, 50 However, the pre-surgical measurements of the 
IAS indicated that the successful patients had a mean of 8.3 (+/-4.4) mm whereas the 3 
patients who did not have success were shown to have a mean IAS of only 6.3 (+/- 1.8) 
mm. Therefore the unsuccessful group had a 24.4% smaller airway measurement prior to 
surgery. Also of interest was the finding that after surgery, the unsuccessful group had a 
larger mean IAS measurement (16.2+/-6.4mm) compared to the successful group (14.3+/- 
3.6mm). This indicates that a larger increase in airway space was achieved for those 3 
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unsuccessful patients, but they still recorded more apnea events per hour than the 
successful group.  
 For the skeletal movements, the difference in the average advancement of the 
maxilla (Sv-Is) and mandible (Sv-Ii) for both the successful and unsuccessful groups was 
not statistically significant (P >.05). In the present study, the mean maxillary 
advancement was 8.8 (+/-3.8) mm and mean mandibular advancement was 12.3 (+/-4.4) 
mm. These advancements are very similar to reported movements in other publications 
where MMA is performed for OSA treatment. 53 However, it was noted that the mean 
horizontal movement of the maxilla in the unsuccessful group was only 6.7 (+/-5.1) mm 
compared to 9.2 (+/-3.6) mm in the successfully treated group. This indicates that the 3 
patients who were not treated successfully had approximately a 27.7% shorter horizontal 
advancement of the maxilla during surgery. The amount of maxillary advancement was 
found to be correlated with treatment success in other studies, as the anterior skeletal 
movement pulled the associated soft tissue with it, resulting in an increase in airway 
dimensions and volume. 42 
 For the angular skeletal measurements, neither the pre-surgical SNA, SNB, nor 
ANB were seen to act as predictors of successful treatment (P >.05). These measurements 
did however provide some indication of the skeletal pattern of the study population. Only 
4 patients in this study had a retrusive maxilla (SNA less than 80 degrees). This indicated 
that most patients in the study had a maxilla that was positioned normally (8 patients), or 
slightly protrusively (10 patients), in relation to the cranial base prior to surgery. This is 
similar to the findings of Ronchi et al. 21, whereby MMA surgery was found to be 
effective in OSA patients, even if no skeletal anomalies were present. 
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 In reference to the SNB values recorded prior to surgery, 12 of 22 patients had a 
value that was retrusive and the remaining 10 patients had values in the normal range. 
This indicated that the majority of the patient population of this study had a retrognathic 
mandible in relation to the cranial base prior to surgery and no patients were observed to 
have prognathic mandibles. The published literature indicates a variety of pre-surgical 
skeletal patterns are possible for OSA patients and the present sample population is 
similar to those reported in other studies 15, 30, 32, 42 
 The mean pre-surgical ANB value for the group was 7.3 (+/-2.6) degrees, which 
is greater than that of the average found in orthodontic control group populations 
(reported as 2.6 (+/-2.0) mm). 46 This elevated ANB value demonstrates that the patient 
population of the present study had a large skeletal discrepancy between the relationship 
of the maxilla and the mandible, which again is reported in other studies. 15  
 The estimated blood loss for the study sample had a mean value of 386.4 (+/- 
114.6) cc. This amount is similar to that reported by Pineiro-Agular 54 in a review of 
seven studies of orthognathic surgeries that included Le Fort I, BSSO or both and found a 
mean volume of blood loss of 436.1 (+/- 207.89) ml. Panula et al 41 also produced similar 
results in reviewing 655 patients who underwent orthognathic surgery consisting of 
BSSO advancement, BSSO setback, Le Fort I or a combination of BSSO and Le Fort I. 
For all procedures an average blood loss of 451 ml was reported.  
 For the present study, there were no fatal complications, no loss of any bony 
segments, and no tooth loss. Again, these results are similar to those in the published 
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literature and indicate that MMA surgery is safe with very few complications related to 
surgical procedure (Appendix XIX).  15, 41, 42, 51, 54 
 Historically, surgical treatments for obstructive sleep apnea have been categorized 
by medical professionals as phase I and phase II procedures with the intention that a 
phased approach would allow for the least amount of surgical intervention to be 
implemented. 55 However, this phased approach has been shown to be ineffective in many 
patients who do not benefit from the “less invasive” phase I surgical procedures. 49 
Surgeons are now aiming for a more patient-specific approach with individualized 
treatment plans designed to increase the likelihood of success by choosing an appropriate 
surgical technique that will address the site of obstruction. 20, 22 Therefore a phased 
approach should no longer be the standard of care and authors in recent publications have 
stopped using the phase I/phase II terminology to avoid the implication that procedures 
which were previously considered as phase II should only follow phase I treatments. 15, 22, 
49  
 The sample population from which this study has been constructed is dependent 
upon referrals from physicians specializing in sleep medicine and therefore is inherently 
biased. These physicians conduct the polysomnography studies and then, based on their 
analysis, interpretation, and discussion with the patient, must decide whether or not the 
patient could benefit from surgery. Then the sleep physician must propose the surgical 
option to the patient and allow the patient to decide if they wish to pursue a consult with 
an oral surgeon to discuss the risks and benefits of the procedure. Therefore, the 
population that proceeds to the surgical consult is heavily controlled by the sleep 
physicians and patients deemed to have too low of an AHI, too high of a BMI, or those 
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with only moderate motivation, may never get consulted regarding surgery. Also, it is 
possible that patients may be given a surgical option but have success with other 
treatments, including CPAP or oral appliances. It is also likely that in some 
circumstances patients may only be referred for MMA surgery as a last resort after less 
invasive treatments have failed. It was therefore apparent that the patients selected for the 
sample population of this study had complex medical histories spanning numerous years, 
and were therefore not selected from a random sample. 
 This study included patients with AHI levels that were mostly moderate and 
severe, however, the investigators also chose to include 2 patients who had AHI scores in 
the mild category prior to surgery. This acted to lower the mean AHI of the pre-surgical 
population and also, as previously mentioned, these patients already met one of the two 
criteria that could qualify a patient as being successfully treated (AHI score of below 15).  
Therefore to be considered as successful, these 2 patients had to meet the other criteria of 
a 50% AHI reduction after surgery. Both patients achieved this standard and were 
included in the study to demonstrate that patients in the mild category of OSA can also 
exhibit significant improvements from MMA surgery. This was demonstrated by their 
AHI reductions of -92.5% and -90.7% and also their improved subjective ESS scores of 
83.3% and 42.9%.  
  Dates listed in Appendix XXI indicate that for some patients there was a large 
range of time between the pre-surgical polysomnography (PSG) study and the date of 
surgery (mean number of months prior to surgery was 49.3 +/- 27.1). Post-surgical 
polysomnography studies had a much smaller mean of 15.7 (+/- 9.4) months after 
surgery. The large spans of time between the pre-surgical PSG study and the surgery date 
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may not account for any changes in AHI (worsening or improvement) that could have 
occurred in this time span and therefore comparing the post-surgery PSG to the original 
PSG may not be as accurate of a comparison if a large amount of time has occurred 
between the two studies. Patient availability, willingness to participate, surgical 
scheduling conflicts, and variations in wait list times for the overnight sleep studies may 
all contribute to the likelihood of having a sleep study done at a time closer to the 
surgical date. None of the previously published studies that were examined reported the 
dates of the pre or post-PSG studies in reference to surgical dates and therefore a 
comparison to the literature was not possible.  
 The surgical movements that were recorded in this study were done on 
radiographs taken immediately pre and post-surgically so there would have been only 
skeletal movements with no orthodontic movement between radiographs. However, the 
surgical movements were only measured on the horizontal plane. It is expected that some 
vertical movement also occurred during the surgical procedures, but this was not 
accounted for in the horizontal measurements that were reported. Additional investigation 
into the effect of the vertical surgical movements on success and cure of treatment should 
be considered for future study of this sample population. 
 The reliability of both the person scoring the sleep study and the reproducibility 
of sleep studies may also be discussed as a limitation of the study. The scoring variability 
between polysomnography technologists was investigated by Collop. 56 Eleven 
technologists in nine laboratories all utilized the same scoring system (Oxford Medilog 
SAC) to evaluate the same eleven sleep studies for evaluation of OSA. The results 
indicated that there was significant variability in scoring of respiratory events. Four 
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studies had a range of scores from none to moderate and one study had a range from none 
to severe, depending on which technologist scored the test. The researcher concluded that 
there could be large variations in scoring, depending on the technologist’s interpretation 
of the rules for testing.  
 The test-retest reliability of overnight polysomnography was investigated by 
Levendowski et al. 57 The purpose of the research was to evaluate the reliability of 
laboratory polysomnography at an interval of at least one month (mean of 40 +/- 11.9 
days between tests). The results of the study indicated that there was variation between 
the two PSG studies with an average increase of 7 events per hour during the second 
study. Twenty-five percent of the patients tested produced an increase of 20 events per 
hour on the consecutive study with only forty-five percent of patients tested having a 
variation of less than 5 events per hour in consecutive studies. Similar variations in 
sequential studies were observed by Chediak 58 and Carlile. 59 Therefore having multiple 
sleep centres where each patient only has a single study completed, which is interpreted 
by a variety of technologists and/or physicians, may lead to bias in the scoring of the 
study.  
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Conclusions 
This retrospective study examined the pre- and post-surgical polysomnograms and 
radiographs of patients suffering from obstructive sleep apnea to evaluate the treatment 
effects of maxillomandibular advancement surgery. The following conclusions were 
derived: 
1. Maxillomandibular advancement surgery is a safe and effective treatment for 
obstructive sleep apnea with 86.4% of patients experiencing a successful result, 
and 36.4% obtaining a cure.  
2. Subjective self-assessment of sleepiness levels was reduced by an average score 
of 5.7 on the Epworth Sleepiness Scale, which placed 88.9% of patients below a 
score of 10. 
3. Among the small sample group tested, AHI, BMI, ESS, IAS, SNA, SNB, gender, 
age, maxillary advancement and mandibular advancement could not be 
considered predictors of successful treatment for this patient population. 
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Suggestions for Prospective Research Studies: 
1) To allow for a more direct comparison between the study populations, it 
would be ideal to have all patients referred from the same sleep clinic and to 
have their PSG studies interpreted by one standardized sleep physician both 
before and after surgery.  
2) If possible, polysomnography studies should be conducted at a standard time 
point prior to and after surgery and it may be beneficial to have multiple 
studies done to confirm or average the scores. 
3) An accepted definition of successful surgical treatment should be established 
for obstructive sleep apnea patients treated at London Health Sciences Centre.  
4) Epworth Sleepiness Scale scores should be reported for all patients before and 
after sleep studies at all participating sleep laboratories. Functional Outcomes 
of Sleep Questionnaires could also be given to patients in addition to the 
Epworth Sleepiness Scale to allow for a more detailed subjective analysis and 
to allow for comparison to other published literature. 
5) Cone Beam Computed Tomography could be considered for method of airway 
assessment before and after surgery to allow for airway volume calculation 
and comparisons to other published literature. 
6) Long-term follow up studies of this patient population should be completed to 
establish the long-term prognosis for treatment (very few long-term studies 
currently available in the published literature). 
7) All patients should be asked at follow-up appointments if they have 
completely eliminated the need for CPAP and/or any other sleep appliances. 
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Figure 1 
Cephalometric landmarks included: 1. Sella 2. Nasion 3. Anterior Nasal Spine 4. A-point 
5. Incisor Superiorus (upper incisal tip) 6. Incisor Inferiorus (lower incisal tip) 7. B-point 
8. Pogonion 9. Menton 10. Gonion 11. Basion 12. Posterior Nasal Spine 13. Incisor 
Inferiorus (root apex) 14. Incisor Superiorus (root apex) 15. Articulaire 16. Anterior 
inferior airway (AIA) 17. Posterior inferior airway (PIA). 
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Figure 2 
Linear Measurements:  
Constructed Frankfurt horizontal: labelled as the x-axis (SN-7°). 
Sella-Vertical (Sv) : labelled as the y-axis.  
Sella-Vertical to Incisor Inferiorus (Sv-Ii): representation of the horizontal position of the 
mandible.  
Sella-vertical to Incisor Superiorus (Sv-Is): representation of the horizontal position of 
the maxilla. 
Inferior airway space (IAS): measured from AIA to PIA at the most occluded point of the 
oropharynx. 
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Figure 3 
Angular Measurements:  
 Sella-Nasion-A-point (SNA): Position of maxilla in reference to the cranial base. 
Measured in degrees.  
Sella-Nasion-B-Point (SNB): Position of mandible in reference to the cranial base. 
Measured in degrees. 
A-point-Nasion-B-point (ANB): Position of maxilla in reference to the position of the 
mandible. Measured in degrees. 
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Appendix I 
The Epworth Sleepiness Scale 16 
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Appendix III 
Dates of pre- and post-surgical radiographs. 
 
 
 
 
 
Patient 
Pre-Surgical 
Radiograph 
Post-Surgical 
Radiograph 
#1 Jan, 2011 Jan, 2011 
#2 Sept,2009 Sept,2009 
#3 March, 2013 March, 2013 
#4 Nov, 2008 Dec, 2008 
#5 Dec, 2006 Dec,2006 
#6 Sept,2008 Oct,2008 
#7 March, 2009 March, 2009 
#8 Jan, 2013 Jan, 2013 
#9 Feb, 2013 April, 2013 
#10 Sept, 2013 Sept, 2013 
#11 Sept,2007 Oct, 2007 
#12 Dec,2002 June, 2003 
#13 Feb,2010 March, 2010 
#14 Feb,2013 March, 2013 
#15 March, 2003 May, 2003 
#16 April, 2005 May, 2005 
#17 Feb, 2006 Feb, 2006 
#18 July,2007 July, 2007 
#19 Jan,2002 March,2002 
#20 Jan, 2012 Jan, 2012 
#21 March, 2009 April, 2009 
#22 Sept,2006 Sept,2006 !
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Appendix IV 
Measurement Error and Reproducibility of Cephalometric Variables 
 
Measure	   Measurement	  Error	   Dhalberg	  Reproducibility	  
SNA	   0.95	  degrees	   0.91	  
SNB	   0.50	  degrees	   0.96	  
ANB	   0.57	  degrees	   0.92	  
IAS	   0.41	  mm	   0.91	  
Sv-­‐Ii	   0.62	  mm	   0.96	  
Sv-­‐Is	   1.06	  mm	   0.91	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Appendix V 
Body Mass Index before surgery (BMI Pre), after surgery (BMI Post), change in Body 
Mass Index (BMI Change), classification before surgery (Pre-Class), after surgery (Post-
Class) and if the patient was successfully treated (Y= yes, N= no). 
 
Patient BMI 
Pre 
BMI 
Post 
BMI 
Change 
Pre-Class  Post-Class Success 
#1 22.0 22.6 0.6 Healthy Healthy Y 
#2 27.4 30.2 2.8 Overweight Obese Y 
#3 26.5 25.4 -1.1 Overweight Overweight N 
#4 25.2 23.6 -1.6 Overweight Healthy Y 
#5 28.0 37.5 9.5 Overweight Obese Y 
#6 26.8 32.4 5.6 Overweight Obese Y 
#7 36.4 33.3 -3.1 Obese Obese Y 
#8 19.0 19.2 0.2 Healthy Healthy N 
#9 29.1 28.1 -1.0 Overweight Overweight N 
#10 36.0 38.7 2.7 Obese Obese Y 
#11 25.5 23.5 -2.0 Overweight Healthy Y 
#12 29.2 29.6 0.4 Overweight Overweight Y 
#13 26.4 26.4 0.0 Overweight Overweight Y 
#14 33.2 34.7 1.5 Obese Obese Y 
#15 25.1 29.8 4.7 Overweight Overweight Y 
#16 33.1 36.5 3.4 Obese Obese Y 
#17 29.8 29.5 -0.3 Overweight Overweight Y 
#18 28.0 33.6 5.6 Overweight Obese Y 
#19 26.7 24.4 -2.3 Overweight Healthy Y 
#20 32.1 33 0.9 Obese Obese Y 
#21 24.2 22.5 -1.7 Healthy Healthy Y 
#22 30.3 27.3 -3.0 Obese Overweight Y 
MEAN 28.2 29.2 0.99     19/22 
Range 19.0-
36.4 
19.2-
38.7 
(-3.1)-
(9.5) 
      
S.D.  4.2 5.4 3.2       
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Appendix VI 
AHI data for the entire treatment population including: patient number, apnea-hypopnea 
index prior to surgery (AHI pre), apnea-hypopnea index after surgery (AHI post), change 
in apnea-hypopnea index (AHI change), percent change in apnea-hypopnea index (% 
Change), classification prior to surgery (Pre-Class), classification after surgery (Post-
Class), those who were successfully treated (Success) and those who were classified as 
cured (Cure).  
Mean, range and standard deviation (S.D.) are also reported. 
 
 
Patient'
(N=22)'
AHI'
Pre'
AHI'
Post'
AHI'
Change'
%'
Change'
Pre7
Class'
Post7
Class'
Success' Cure'
#1# 13.3' 1' 712.3' 792.5' Mild' Normal' Y' Y'
#2# 35' 6.1' 728.9' 782.6' Severe' Mild' Y' N'
#3# 29' 35.8' 6.8' 23.8' Mod' Severe' N' N'
#4# 11.5' 0.8' 710.7' 790.7' Mild' Normal' Y' Y'
#5# 99.8' 17.2' 782.6' 782.8' Severe' Mod' Y' N'
#6# 120.2' 29.7' 790.5' 775.3' Severe' Mod' Y' N'
#7# 27' 1.5' 725.5' 794.4' Mod' Normal' Y' Y'
#8# 18.2' 26.6' 8.4' 46.2' Mod' Mod' N' N'
#9# 62.5' 59.4' 73.1' 75' Severe' Severe' N' N'
#10# 52.6' 18.9' 733.7' 764.1' Severe' Mod' Y' N'
#11# 29.6' 0.2' 729.4' 799.3' Mod' Normal' Y' Y'
#12# 73.6' 17.1' 756.5' 776.8' Severe' Mod' Y' N'
#13# 49.4' 24.2' 725.2' 751' Severe' Mod' Y' N'
#14# 40' 6.2' 733.8' 784.5' Severe' Mild' Y' N'
#15# 21.5' 5.9' 715.6' 772.6' Mod' Mild' Y' N'
#16# 80.3' 28.2' 752.1' 764.9' Severe' Mod' Y' N'
#17# 30.3' 3.3' 727' 789.1' Severe' Normal' Y' Y'
#18# 107.5' 3.4' 7104.1' 796.8' Severe' Normal' Y' Y'
#19# 46.8' 1.2' 745.6' 797.4' Severe' Normal' Y' Y'
#20# 64.1' 13.2' 750.9' 779.4' Severe' Mild' Y' N'
#21# 32.5' 5.1' 727.4' 784.3' Severe' Mild' Y' N'
#22# 19.1' 3.9' 715.2' 779.6' Mod' Normal' Y' Y'
MEAN' 48.4# 14.0# .34.3# .67.9# # # 19/22# 8/22#
RANGE' 11.5.
120.2#
0.2.
59.4#
104.1#
.8.4#
.99.3.
46.2#
# # # #
S.D.' 31.3# 15.0# 29.4# 39.1# # # # #!
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Appendix VII 
AHI data for only those patients in the treatment population who met the criteria of 
success (Defined as AHI reduction to below score of 15 or a 50% reduction in AHI). 
Data presented includes success, Patient #, age of patient measured in years (Age Yrs), 
pre-surgical AHI score (AHI Pre), post-surgical AHI score (AHI Post), change in AHI 
score (AHI Change), percent change in AHI score (% Change), pre-surgical OSA 
classification (Pre-class), and post-surgical OSA classification.  
*Note that for the category of Post-Class, the term “Normal” represents a cure from OSA 
 
 
 
Success Patient 
# 
Age 
(Yrs) 
AHI Pre 
 
AHI 
Post 
AHI 
Change 
% 
Change 
Pre-
Class 
Post-
Class 
YES #1 45.7 13.3 1 -12.3 -92.5 Mild Normal 
YES #2 35.6 35 6.1 -28.9 -82.6 Severe Mild 
YES #4 44.3 11.5 0.8 -10.7 -90.7 Mild Normal 
YES #5 16 99.8 17.2 -82.6 -82.8 Severe Mod 
YES #6 49.9 120.2 29.7 -90.5 -75.3 Severe Mod 
YES #7 52.7 27 1.5 -25.5 -94.4 Mod Normal 
YES #10 36.6 52.6 18.9 -33.7 -64.1 Severe Mod 
YES #11 42.1 29.6 0.2 -29.4 -99.3 Mod Normal 
YES #12 44.4 73.6 17.1 -56.5 -76.8 Severe Mod 
YES #13 59.9 49.4 24.2 -25.2 -51.0 Severe Mod 
YES #14 36.8 40 6.2 -33.8 -84.5 Severe Mild 
YES #15 29.1 21.5 5.9 -15.6 -72.6 Mod Mild 
YES #16 57.6 80.3 28.2 -52.1 -64.9 Severe Mod 
YES #17 52.3 30.3 3.3 -27 -89.1 Severe Normal 
YES #18 19.2 107.5 3.4 -104.1 -96.8 Severe Normal 
YES #19 31.1 46.8 1.2 -45.6 -97.4 Severe Normal 
YES #20 29.3 64.1 13.2 -50.9 -79.4 Severe Mild 
YES #21 47.6 32.5 5.1 -27.4 -84.3 Severe Mild 
YES #22 48.4 19.1 3.9 -15.2 -79.6 Mod Normal 
MEAN   41.0 50.2 9.8 -40.4 -82.0 !! !!
Range   (16.0)-
(59.) 
(11.5)-
(120.2) 
(0.2)-
(29.7) 
(104.1)-
(-10.7) 
(-51)- 
(-97.4) 
    
S.D.   12.2 32.5 9.8 26.8 12.7     !
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Appendix VIII 
AHI data for only those patients in the treatment population who did not meet the criteria 
of success (Defined as AHI reduction to below score of 15 or a 50% reduction in AHI).  
Data presented include success, Patient #, age of patient measured in years (Age Yrs), 
pre-surgical AHI score (AHI Pre), post-surgical AHI score (AHI Post), change in AHI 
score (AHI Change), percent change in AHI score (% Change), pre-surgical OSA 
classification (Pre-class), and post-surgical OSA classification.  
*Note that for the category of Post-Class, the term “Normal” represents a cure from OSA 
 
 
 
 
 
 
 
Success Patient 
# 
Age 
(yrs) 
AHI Pre AHI 
Post 
AHI 
Change 
% 
Change 
Pre- 
Class 
Post-
Class 
NO #3 62.3 29 35.8 6.8 23.8 Mod Severe 
NO #8 55.7 18.2 26.6 8.4 46.2 Mod Mod 
NO #9 71.4 62.5 59.4 -3.1 -5 Severe Severe 
MEAN   63.1 36.6 40.6 4 21.7     
RANGE   (55.7)-
(71.4) 
(18.2)-
(62.5) 
(26.6)-
(59.4) 
(-3.1)-
(8.4) 
(-5)-
(46.2) 
    
S.D.   7.9 23.1 16.9 6.2       !
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Appendix IX 
Pre-surgical Epworth Sleepiness Scale scores (Pre ESS), post-surgical Epworth 
Sleepiness Scale scores (Post ESS), pre-surgical classification (Pre-Class), post-surgical 
classification (Post-Class) and change in score on the Epworth Sleepiness Scale (ESS 
Change). Mean, range and standard deviations are reported where appropriate. 
*Note: For Pre-Class and Post-Class Columns, Normal ≤ 9, Excessive ≥ 10  
 
 
Patient Pre 
ESS 
Post 
ESS 
Pre-Class Post-Class ESS 
Change 
% ESS 
Change 
#1 6 1 Normal Normal -5 -83.3 
#2 3 2 Normal Normal -1 -33.3 
#3 17 4 Excessive Normal -13 -76.5 
#4 14 8 Excessive Normal -6 -42.9 
#5 15 3 Excessive Normal -12 -80.0 
#6 4 14 Normal Excessive 10 +250.0 
#7 9 4 Normal Normal -5 -55.6 
#8 10 5 Excessive Normal -5 -50.0 
#9 13 6 Excessive Normal -7 -53.8 
#10 18 4 Excessive Normal -14 -77.8 
#11 14 5 Excessive Normal -9 -64.3 
#12 7 4 Normal Normal -3 -42.9 
#13 15 7 Excessive Normal -8 -53.3 
#14 12 7 Excessive Normal -5 -41.7 
#15 15 14 Excessive Excessive -1 -6.7 
#16 7 5 Normal Normal -2 -28.6 
#17 15 3 Excessive Normal -12 -80.0 
#18 N/A N/A N/A N/A N/A  
#19 N/A N/A N/A N/A N/A  
#20 15 6 Excessive Normal -9 -60.0 
#21 N/A N/A N/A N/A N/A  
#22 N/A N/A N/A N/A N/A  
MEAN 11.6 5.7   -5.7 -37.8 
RANGE (3)-
(18) 
(1)-
(14) 
  (-14)-
(10) 
(-83.3)-
(250.0) 
S.D. 4.6 3.5   5.5 74.7 !
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Appendix X 
 
Graph 1: Pre to post-treatment changes of AHI vs. pre to post-treatment changes of ESS.  
A mild negative correlation was detected, however there was no statistically significant 
relationship. (r = -.461; P =. 054). 
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Appendix XI 
 
Graph 2. Change in BMI compared to change in AHI score. A moderate negative 
correlation was detected (r = -.661, P< .001). 
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Appendix XII 
Values for pre-surgical Sella-Nasion-A-Point (SNA), pre-surgical Sella-Nasion-B-Point 
(SNB), and pre-surgical A-point-Nasion-B-Point (ANB). 
 
 
 
 
Patient Pre-SNA 
(deg) 
Pre-SNB 
(deg) 
Pre-ANB 
(deg) 
#1 90.5 79.0 11.5 
#2 81.8 70.0 11.8 
#3 81.3 73.6 7.7 
#4 78.3 70.6 7.8 
#5 81.7 76.2 5.5 
#6 83.7 73.4 10.4 
#7 86.8 79.0 7.9 
#8 76.6 70.8 5.8 
#9 90.3 82.7 7.6 
#10 82.0 80.6 1.4 
#11 81.7 76.6 5.1 
#12 77.8 72.6 5.2 
#13 85.2 80.9 4.3 
#14 86.5 79.5 7.0 
#15 87.0 81.5 5.5 
#16 86.0 78.1 7.8 
#17 87.1 79.1 8.0 
#18 82.1 71.9 10.2 
#19 79.7 76.4 3.3 
#20 88.4 80.9 7.5 
#21 82.0 72.1 9.9 
#22 86.4 77.7 8.7 
MEAN 83.8 76.5 7.3 
RANGE 77.8-90.5 70.0-82.7 1.4-11.8 
S.D. 3.9 4.0 2.6 !
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Appendix XIII 
Lateral cephalometric measurements of the pre-surgical Inferior Airway Space (IAS Pre), 
post-surgical IAS (IAS Post), change in airway space size (IAS Change), percent change 
in airway space (% Change) and treatment success (Yes = Y, No = N). 
 
 
 
Patient IAS Pre 
(mm) 
IAS Post 
(mm) 
IAS 
Change 
(mm) 
 % Change Success 
#1 5.7 12.5 6.8 119.3 Y 
#2 5.0 17.1 12.1 242 Y 
#3 6.8 9.3 2.5 36.8 N 
#4 3.7 11.0 7.3 197.3 Y 
#5 9.8 10.5 0.7 7.1 Y 
#6 2.7 20.0 17.3 640.7 Y 
#7 5.4 13.3 7.9 146.3 Y 
#8 4.3 17.3 13.0 302.3 N 
#9 7.8 22.0 14.2 182.1 N 
#10 19.2 20.1 0.9 4.7 Y 
#11 9.3 13.0 3.7 39.8 Y 
#12 6.4 9.9 3.5 54.7 Y 
#13 4.8 16.8 12.0 250.0 Y 
#14 15.3 18.9 3.6 23.5 Y 
#15 7.8 14.0 6.2 79.5 Y 
#16 10.8 16.5 5.7 52.8 Y 
#17 4.7 8.1 3.4 42.0 Y 
#18 10.0 16.3 6.3 63.0 Y 
#19 10.1 14.7 4.6 45.5 Y 
#20 14.8 17.9 3.1 20.9 Y 
#21 5.3 11.0 5.7 107.5 Y 
#22 7.4 11.5 4.1 55.4 Y 
MEAN 8.1 14.6 6.6 123.3   
RANGE 2.7-19.2 9.3-20.1 0.7-17.3 4.7-640.7   
S.D. 4.1 3.9 4.5 143.9   !
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Appendix XIV 
 
Graph 3: The change in inferior airway space in reference to change in the apnea-
hypopnea index produced virtually no correlation and was not statistically significant     
(r =.079; P =.725). 
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Appendix XV 
Maxillary advancement distance:  
Pre-surgical Sella-Vertical to Incisor Superiorus (Pre-Sv-Is) 
Post-surgical Sella-Vertical to Incisor Superiorus (Post-Sv-Is)  
Change from pre- to post-surgery (Change SV to Is). 
 
 
 
 
Patient Pre-SV-Is 
(mm) 
Post-SV-Is 
(mm) 
Change SV to Is 
(mm) 
#1 84.8 94.7 9.9 
#2 67.4 75.7 8.3 
#3 75.5 76.4 0.9 
#4 66.3 74.3 8.0 
#5 62.8 69.7 6.9 
#6 74.2 82.9 8.7 
#7 74.9 88.9 14.0 
#8 63.5 73.3 9.8 
#9 81.0 90.5 9.5 
#10 76.8 90.3 13.5 
#11 68.2 74.0 5.8 
#12 64.3 72.7 8.4 
#13 69.8 80.6 10.8 
#14 87.1 90.8 3.7 
#15 81.7 88.0 6.3 
#16 81.9 86.1 4.2 
#17 78.6 85.6 7.0 
#18 65.9 82.3 16.4 
#19 68.8 75.5 6.7 
#20 74.5 86.5 12.0 
#21 67.7 82.7 15.0 
#22 75.1 83.4 8.3 
MEAN 73.2 82 8.8 
RANGE 62.8-87.1 69.7-94.7 0.9-16.4 
S.D.  7.2 7.1 3.8 !
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Appendix XVI 
 
Graph 4. The change in AHI score and the change in maxillary movement (Sv-Is) were 
compared and there was no significant correlation (r = -.260; P = .242) 
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Appendix XVII 
Mandibular advancement distance: 
Pre-surgical Sella-Vertical to Incisor Inferiorus (Pre-Sv-Ii) 
Post-surgical Sella-Vertical to Incisor Inferiorus (Post-Sv-Ii) 
Change from pre to post-surgery (Change Sv-Ii). 
 
 
 
Patient Pre-Sv-Ii 
(mm) 
Post-Sv-Ii 
(mm) 
Change Sv-Ii 
(mm) 
#1 76.8 92.1 15.3 
#2 62.5 74.5 12 
#3 65.8 73.8 8 
#4 57 72.3 15.3 
#5 62.8 67.8 5 
#6 65.6 81.1 15.5 
#7 68.9 86 17.1 
#8 60.2 70.1 9.9 
#9 69.4 86.2 16.8 
#10 73.8 86.3 12.5 
#11 65.2 70.3 5.1 
#12 59 69.6 10.6 
#13 64.8 75.3 10.5 
#14 75.9 87.8 11.9 
#15 77.5 84.3 6.8 
#16 73.5 84 10.5 
#17 69 81.8 12.8 
#18 56.8 80.1 23.3 
#19 65.4 72.4 7 
#20 71.7 83.8 12.1 
#21 64.2 80.1 15.9 
#22 65.9 81.7 15.8 
MEAN 66.9 79.2 12.3 
RANGE 57.0-77.5 67.8-92.1 5.0-23.3 
S.D. 6.1 6.9 4.4 !
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Appendix XVIII 
 
Graph 5. The change in mandibular advancement versus change in AHI was compared 
and there was no significant correlation detected (r = -.176; P = .434). 
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Appendix XIX 
Estimated Blood Loss During Surgery and Associated Surgical Complications 
 
 
Patient 
Estimated 
Blood Loss    
(cc) Surgically related complications 
#1 300 N/A 
#2 300 N/A 
#3 400 
Maximum Advancement not achieved, patient 
declined second surgical procedure immediately 
after surgery 
#4 300 N/A 
#5 400 
Developed pneumonia in hospital, complete 
recovery (extended hospital stay for 5 days) 
#6 500 N/A 
#7 400 N/A 
#8 300 N/A 
#9 400 N/A 
#10 400 N/A 
#11 300 N/A 
#12 200 
Non-union of Le Fort, 2nd surgery 6 months later 
with full healing 
#13 350 N/A 
#14 400 N/A 
#15 400 
Dec. 2006 broken plate removed, no further 
treatment required 
#16 300 N/A 
#17 300 N/A 
#18 400 N/A 
#19 500 N/A 
#20 550 N/A 
#21 750 
Surgeon felt advancement was too much, returned 
for 2nd surgery 3 weeks later to reduce the 
advancement 
#22 350 Root canal therapy and internal bleaching on #21 
 Mean 386.4   
 Range 200.0-750.0   
 S.D. 114.6   !
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Appendix XX 
Significant Medical History From Pre-Surgical Evaluations 
 
 
 
Patient 
Confirmed 
cPAP User 
Prior to 
Surgery 
Significant Prior Medical History  
(excluding obesity) 
#1 Y Rheumatoid Arthritis 
#2 Y Depression 
#3 Y TMD, GERD, Scoliosis 
#4 Y Panic attacks, Hypertension, Hypoglycaemia, Mitral Valve Prolapse 
#5 Y Suspicion of syndrome-Pierre Robin (unconfirmed) 
#6 Y Bipolar, fatigue, patient taking multiple psychoactive medications 
#7 Y N/A 
#8 Y Hypothyroidism 
#9 Y Prostate cancer, Previous Myocardial Infarct 
#10 Y N/A 
#11 N N/A 
#12 Y N/A 
#13 Y Deviated septum, Asthma, Hepatitis A, Hypothyroid, GERD 
#14 Y History of sleep walking 
#15 Y Previous UPPP surgery 
#16 Y N/A 
#17 N N/A 
#18 Y Prior Surgery to remove adenoids 
#19 Y Depression 
#20 Y N/A 
#21 Y N/A 
#22 N N/A 
  19/22   !
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Appendix XXI 
Table below indicates dates of pre-surgical polysomnography, dates of surgery, dates of 
post-surgical polysomnography, and number of months after surgery that the post- 
surgical PSG was completed for each patient in the study. 
 
 
 
Patient' 'Pre)Surg'PSG' Months'
Pre)Surg'
Date'of'
Surgery'
'Post)Surg'PSG' Months'post)
Surg'
#1 8/4/2005' 66' 1/24/2011' 6/26/2012' 15.00 
#2 10/8/2005' 47' 9/29/2009' 8/21/2012' 35.00 
#3 2/2/2007' 73' 3/5/2013' 4/28/2014' 13.00 
#4 9/12/2003' 63' 12/8/2008' 9/30/2010' 21.00 
#5 2/7/2003' 46' 12/12/2006' 10/26/'2008' 22.00 
#6 9/26/1999' 108' 10/10/2008' 1/11/2010' 15.00 
#7 9/11/2002' 77' 3/23/2009' 4/7/2011' 25.00 
#8 4/24/2008' 57' 1/14/2013' 11/26/2013' 10.00 
#9 9/8/2008' 55' 4/15/2013' 5/1/2014' 13.00 
#10 4/27/2008' 65' 9/16/2013' 5/8'2014' 8.00 
#11 1/3/2003' 56' 9/4/2007' 10/29/2008' 13.00'
#12 5/28/2002' 12' 5/26/2003' 9/17/2003' 4.00 
#13 4/23/2001' 107' 3/2/2010' 3/1/2011' 12.00 
#14 2/1/2011' 24' 2/25/2013' 11/30/2013' 9.00 
#15 4/2/'2002' 13' 5/2/2003' 12/7/'2007' 43.00 
#16 6/12/2002' 35' 5/10/2005' 'N/A'  N/A 
#17 9/18/2003' 29' 2/13/2006' 12/6/'2006' 10.00 
#18 3/18/'2004' 39' 7/19/2007' 9/19/'2008' 14.00 
#19 5/19/2000' 19' 1/18/2002' 5/26/2002' 4.00 
#20 8/12/2009' 29' 1/16/2012' 4/16/2013' 15.00 
#21 4/1/2005' 48' 4/6/2009' 7/8/2010' 15.00 
#22 3/13/'2005' 17' 9/22/2006' 11/23/2007' 14.00 
MEAN  49.3   15.71 
Range  12-107   4.0-43.0 
S.D.  27.1   9.4 !
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